Document:

COMMITTED EQUITY FACILITY AGREEMENT

 

This Committed Equity
Facility Agreement (the “Agreement”) is dated as of the 31st day of August, 2012, by and between
TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Investor”) and MILLENNIUM
HEALTHCARE, INC., a Delaware corporation (the “Company”).

 

RECITALS

 

WHEREAS, the
parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the
Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $2,000,000 of the
Company’s common stock, $0.0001 par value per share (the “Common Stock”); and

 

WHEREAS, such
investments will be made in reliance upon the provisions of Regulation D (“Regulation D”) of the
Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (collectively, the “Securities
Act”), or upon such other exemption from the registration requirements of the Securities Act as may be
available with respect to any or all of the transactions to be entered into hereunder;

 

NOW, THEREFORE,
in consideration of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound,
agree as follows:

 

ARTICLE I

CERTAIN DEFINITIONS

 

For purposes of this
Agreement, except as otherwise expressly provided or otherwise defined elsewhere in this Agreement, or unless the context otherwise
requires, the capitalized terms in this Agreement shall have the meanings assigned to them in this Article as follows:

 

1.1           “Advance”
shall mean the portion of the Commitment Amount requested by the Company in the Advance Notice.

 

1.2           “Advance
Fee” shall mean an amount in United States funds equal to five percent (5%) of the gross amount of each Advance.

 

1.3           “Advance
Notice” shall mean a written notice in the form of Exhibit “A” attached hereto, executed
by an officer of the Company and delivered to the Investor and setting forth the Advance amount that the Company requests from
the Investor.

 

1.4           “Advance
Notice Date” shall mean each date the Company delivers (in accordance with Section 2.1 of the Agreement) to the Investor
an Advance Notice requiring the Investor to advance funds to the Company, subject to the terms of this Agreement.

 

1.5           “Advance
Shares True-Up Date” shall mean the first (1st) Trading Day after expiration of the applicable Pricing
Period for an Advance.

 

    	1

    	 

    

 

1.6           “Affiliate”
shall have the meaning set forth in Rule 405 of the Securities Act.

 

1.7           “Agreement”
shall have the meaning set forth in the preamble paragraph hereto.

 

1.8           “By-Laws”
shall have the meaning set forth in Section 4.4.

 

1.9           “Certificate
of Incorporation” shall have the meaning set forth in Section 4.4.

 

1.10         “Claims”
shall have the meaning set forth in Section 5.1.

 

1.11         “Clearing
Date” shall mean the date on which the Estimated Advance Shares have been deposited into the Investor’s brokerage
account and the Investor’s broker has confirmed with the Investor that such Estimated Advance Shares have cleared into Investor’s
brokerage account and the Investor may execute trades of such Estimated Advance Shares.

 

1.12         “Closing”
shall mean one of the closings of a purchase and sale of Common Stock pursuant to Section 2.2.

 

1.13         “Closing
Date” shall have the meaning set forth in Section 2.2(c).

 

1.14         “Commitment
Amount” shall mean the aggregate amount of up to $2,000,000 which the Investor has agreed to provide to the Company
in order to purchase the Shares pursuant to the terms and conditions of this Agreement.

 

1.15         “Commitment
Period” shall mean the period commencing on the Effective Date, and expiring upon the termination of this Agreement
in accordance with Section 10.2.

 

1.16         “Common
Stock” shall have the meaning set forth in the recitals of this Agreement.

 

1.17         “Company”
shall have the meaning set forth in the preamble paragraph hereto.

 

1.18         “Company
Indemnitees” shall have the meaning set forth in Section 5.2.

 

1.19         “Condition
Satisfaction Date” shall have the meaning set forth in Article VII.

 

1.20         “Consolidation
Event” shall have the meaning set forth in Section 6.9.

 

1.21         “Effective Date”
shall mean September 18, 2012.

 

1.22         “Environmental
Laws” shall have the meaning set forth in Section 4.9.

 

1.23         “Estimated
Advance Shares” shall have the meaning set forth in Section 2.1(c).

 

1.24         “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

1.25         “Exchange
Cap” shall have the meaning set forth in Section 2.1(d).

 

    	2

    	 

    

 

1.26         “Indemnified
Liabilities” shall have the meaning set forth in Section 5.1.

 

1.27         “Indemnitee”
shall have the meaning set forth in Section 5.3.

 

1.28         “Indemnitor”
shall have the meaning set forth in Section 5.3.

 

1.29         “Investor”
shall have the meaning set forth in the preamble paragraph hereto.

 

1.30         “Investor
Indemnitees” shall have the meaning set forth in Section 5.1.

 

1.31         “Market
Price” shall mean the lowest daily VWAP of the Common Stock during the relevant Pricing Period.

 

1.32         “Material
Adverse Effect” shall mean any condition, circumstance, or situation that has resulted in, or would reasonably be
expected to result in : (i) a material adverse effect on the legality, validity or enforceability of this Agreement or the transactions
contemplated herein; (ii) a material adverse effect on the results of operations, assets, business or condition (financial or otherwise)
of the Company, taken as a whole; or (iii) a material adverse effect on the Company’s ability to perform in any material
respect on a timely basis its obligations under this Agreement.

 

1.33         “Maximum
Advance Amount” shall mean, for each Advance Notice, no more than fifteen percent (15%) of the average daily volume
of shares of Common Stock traded during the immediately preceding five (5) consecutive Trading Days applicable to the relevant
Advance Notice.

 

1.34         “Ownership
Limitation” shall have the meaning set forth in Section 2.1(a).

 

1.35         “Par
Value Payment” shall have the meaning set forth in Section 2.1(c).

 

1.36         “Person”
shall mean an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government
or political subdivision or an agency or instrumentality thereof.

 

1.37         “Preferred
Stock” shall have the meaning set forth in Section 4.4.

 

1.38         “Pricing
Period” shall mean the five (5) consecutive Trading Days immediately following the Clearing Date associated with
the applicable Advance Notice.

 

1.39         “Principal
Market” shall mean the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market, the OTC
Bulletin Board, the OTC Markets, the NYSE Euronext or the New York Stock Exchange, whichever is at the time the principal trading
exchange or market for the Common Stock.

 

1.40         “Purchase
Price” shall be set at ninety-five percent (95%) of the Market Price during the Pricing Period.

 

    	3

    	 

    

 

1.41         “Registrable
Securities” shall mean: (i) the Shares; and (ii) any securities issued or issuable with respect to the Shares by
way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation
or other reorganization or otherwise. As to any particular Registrable
Securities, once issued such securities shall cease to be Registrable Securities when: (a) the Registration Statement has been
declared effective by the SEC and such Registrable Securities have been disposed of pursuant to the Registration Statement; (b)
such Registrable Securities have been sold under circumstances under which all of the applicable conditions of Rule 144 (or any
similar provision then in force) under the Securities Act (“Rule 144”) are met; or (c) in the opinion
of counsel to the Company such Registrable Securities may permanently be sold without registration or without any time, volume or
manner of sale limitations pursuant to Rule 144.

 

1.42         “Registration
Limitation” shall have the meaning set forth in Section 2.1(a).

 

1.43         “Registration
Rights Agreement” shall mean the Registration Rights Agreement dated the date hereof, regarding the filing of the
Registration Statement for the resale of the Registrable Securities, entered into between the Company and the Investor.

 

1.44         “Registration
Statement” shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated by the
SEC for which the Company then qualifies and which counsel for the Company shall deem appropriate, and which form shall be available
for the registration of the resale by the Investor of the Registrable Securities under the Securities Act.

 

1.45         “Regulation
D” shall have the meaning set forth in the recitals of this Agreement.

 

1.46         “SEC”
shall mean the United States Securities and Exchange Commission.

 

l.47         “Securities Act”
shall have the meaning set forth in the recitals of this Agreement.

 

1.48         “Settlement
Document” shall have the meaning set forth in Section 2.2(a).

 

1.49         “Shares”
shall mean the shares of Common Stock to be issued from time to time hereunder pursuant to Advances, and shall include the Estimated
Advance Shares required to be delivered to Investor hereunder.

 

1.50         “Trading
Day” shall mean any day during which the Principal Market shall be open for business.

 

1.51         “VWAP”
means, for any Trading Day, the daily volume weighted average price of the Common Stock for such date on the Principal Market as
reported by Bloomberg L.P. (based on a Trading Day from 9:00 a.m. (New York City time) to 4:02 p.m. (New York City time)).

 

ARTICLE II

ADVANCES

 

2.1           Advances;
Mechanics. Subject to the terms and conditions of this Agreement (including, without limitation, the conditions of Article
VII hereof), the Company, at its sole and exclusive option, may issue and sell to the Investor, and the Investor shall purchase
from the Company, shares of Common Stock on the following terms:

 

    	4

    	 

    

 

(a)          Advance
Notice. At any time during the Commitment Period, the Company may require the Investor to purchase shares of Common Stock
by delivering an Advance Notice to the Investor, subject to the conditions set forth in Article VII; provided, however, that:
(i) the amount for each Advance as designated by the Company in the applicable Advance Notice shall not be more than the Maximum
Advance Amount; (ii) the aggregate amount of the Advances pursuant to this Agreement shall not exceed the Commitment Amount; (iii)
in no event shall the number of Shares issuable to the Investor pursuant to an Advance cause the aggregate number of Shares beneficially
owned (as calculated pursuant to Section 13(d) of the Exchange Act) by the Investor and its Affiliates to exceed 4.99% of the
then outstanding Common Stock (the “Ownership Limitation”); (iv) if the Common Stock is listed or quoted
on The Nasdaq Stock Market or any other U.S. national securities exchange during the Commitment Period, in no event shall the
number of shares of Common Stock issuable to the Investor pursuant to an Advance Notice cause the aggregate number of shares of
Common Stock that would be issued pursuant to this Agreement, together with all shares of Common Stock issued pursuant to any
transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of The Nasdaq
Stock Market or any other Principal Market on which the Common Stock may be listed or quoted, to exceed the Exchange Cap; and
(v) in no event shall the aggregate offering price or number of Shares, as the case may be, exceed the aggregate offering price
or number of Shares, as the case may be, available for issuance under the Registration Statement (the “Registration
Limitation”). In connection with each Advance Notice delivered by the Company, if any portion of the applicable
Advance, or the Shares issuable to Investor pursuant to such Advance, would result in any of the limitations set forth in this
Section 2.1(a) to be exceeded, such portion of such Advance shall be void ab initio and automatically be deemed to be withdrawn
by the Company with no further action required by the Company or the Investor, and the amount of proceeds ultimately due to the
Company under such Advance shall be reduced accordingly. Upon the written or oral request of the Investor, the Company shall confirm
orally or in writing to the Investor, within two (2) Trading Days of such request, the number of shares of Common Stock then issued
and outstanding, or any other information the Investor may request, so that the Investor may properly analyze and make the determinations
required to insure that none of the limitations set forth in this Section 2.1(a) shall ever be exceeded.

 

(b)          Date
of Delivery of Advance Notice. Advance Notices shall be delivered in accordance with the instructions set forth on the bottom
of Exhibit “A”. An Advance Notice shall be deemed delivered on: (i) the Trading Day it is received by
the Investor, if such Advance Notice is received prior to 5:00 pm, Eastern Time; or (ii) the immediately succeeding Trading Day
if such Advance Notice is received by Investor after 5:00 pm, Eastern Time, on a Trading Day or at any time on a day which is not
a Trading Day. No Advance Notice may be deemed delivered on a day that is not a Trading Day, or if positive receipt of such Advance
Notice is not acknowledged by the Investor. Unless the parties agree in writing otherwise, there shall be a minimum of five (5)
Trading Days between a Closing Date and a subsequent Advance Notice Date.

 

(c)          Delivery
of Estimated Advance Shares. On an Advance Notice Date, the Company shall deliver to the Investor’s brokerage account
(pursuant to instructions provided by the Investor) an estimated number of Shares, rounded up to the nearest whole share, equal
to the Advance indicated in the applicable Advance Notice divided by the lowest daily VWAP on the Trading Day immediately preceding
the Advance Notice Date, multiplied by two hundred percent (200%) (the “Estimated Advance Shares”). On
the Trading Day immediately following the Clearing Date applicable to the then applicable Advance Notice, the Investor shall acknowledge
consideration by allocating funds in the Investor’s brokerage account in an amount equal to the par value of the Estimated
Advance Shares (“Par Value Payment”), which Par Value Payment shall be held in the Investor’s brokerage
account for the duration of the Pricing Period and adjusted at the Closing as hereinafter set forth. Under no circumstances shall
the Par Value Payment exceed the amount of the Advance specified in the Advance Notice and no Advance Notice shall be delivered
to the Investor if the Company’s Common Stock is trading at or below its par value. The Company acknowledges and agrees that,
notwithstanding anything contained in this Agreement to the contrary, the Investor may sell shares of the Company’s Common
Stock relating to a particular Advance Notice, including, without limitation, all of the Estimated Advance Shares in the Investor’s
brokerage account on the Clearing Date with respect to such Advance Notice, at any time after the Advance Notice is received by
the Investor. If the amount of Estimated Advance Shares due to be delivered to the Investor pursuant to a particular Advance Notice
would result in the Investor exceeding the Ownership Limitation, then the amount of the Advance requested in the Advance Notice
shall be automatically reduced the Estimated Advance Shares shall be automatically reduced to an amount that would allow for delivery
by the Company to Investor of Estimated Advance Shares for the full two hundred percent (200%) contemplated hereby, without exceeding
the Ownership Limitation.

 

    	5

    	 

    

 

(d)          Exchange
Cap. If the Common Stock is listed or quoted on The Nasdaq Stock Market or any other U.S. national securities exchange during
the Commitment Period, the Company shall not issue or sell any shares of Common Stock pursuant to this Agreement, and the Investor
shall not purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent that after giving effect thereto,
the aggregate number of all shares of Common Stock that would be issued pursuant to this Agreement, together with all shares of
Common Stock issued pursuant to any transactions that may be aggregated with the transactions contemplated by this Agreement under
applicable rules of The Nasdaq Stock Market or any other Principal Market on which the Common Stock may be listed or quoted, would
exceed the maximum number of shares of Common Stock that the Company may issue pursuant to this Agreement and the transactions
contemplated hereby without: (i) breaching the Company’s obligations under the applicable rules of The Nasdaq Stock Market
or any other Principal Market on which the Common Stock may be listed or quoted; or (ii) obtaining stockholder approval under the
applicable rules of The Nasdaq Stock Market or any other Principal Market on which the Common Stock may be listed or quoted (the
“Exchange Cap”). In such a circumstance, any portion of the applicable Advance, or the Shares issuable
to Investor pursuant to such Advance, that would exceed the Exchange Cap to be exceeded shall be void ab initio and automatically
be deemed to be withdrawn by the Company with no further action required by the Company or the Investor, unless and until the Company
elects to solicit stockholder approval of the transactions contemplated by this Agreement and the stockholders of the Company have
in fact approved the transactions contemplated by this Agreement in accordance with the applicable rules and regulations of The
Nasdaq Stock Market, any other Principal Market on which the Common Stock may be listed or quoted, and the Certificate of Incorporation
and Bylaws of the Company.

 

2.2           Closings.
Each Closing shall take place on a Closing Date in accordance with the procedures set forth below. In connection with each Closing,
the Company and the Investor shall fulfill each of its obligations as set forth below:

 

(a)          Settlement
Document. Subject to the terms and conditions of this Agreement, the Investor promptly shall notify the Company in writing
of the occurrence of the Clearing Date associated with an Advance Notice. The Pricing Period with respect to such Advance Notice
shall begin on the first (1st) Trading Day immediately following the applicable Clearing Date. At the end of the Pricing
Period, the Investor shall deliver to the Company a written document (each a “Settlement Document”)
setting forth: (i) the amount of the Advance (taking into account any adjustments pursuant to Section 2.1 above); (ii) the
Purchase Price; (iii) the Market Price (as supported by a report by Bloomberg L.P. indicating the VWAP for each of the Trading
Days during the Pricing Period); and (iv) the number of Shares to be issued and subscribed for in connection with the applicable
Advance (which in no event will be greater than the Ownership Limitation, the Exchange Cap, or the Registration Limitation), in
each case taking into account any adjustments and/or reductions under the terms and conditions of this Agreement. The Settlement
Document shall be in the form attached hereto as Exhibit “B”.

 

    	6

    	 

    

 

(b)          Confirmation
of Settlement Document.         Upon receipt of the Settlement Document with respect
to each Advance, the Company shall, by promptly (and in any event not later than one (1) Trading Day after receipt) signing the
Settlement Document and returning it to the Investor, confirm that it has obtained all permits and qualifications, if any, required
for the issuance and transfer of the Shares applicable to such Advance, or shall have the availability of exemptions therefrom,
and that the sale and issuance of such Shares shall be legally permitted by all laws and regulations to which the Company is subject.
Execution of the Settlement Document by the Company shall also be deemed a representation by the Company that all conditions to
an Advance under Article VII have been fully satisfied in all material respects as of each Condition Satisfaction Date.

 

(c)          True-Up
Date and Closing Date. If the number of Estimated Advance Shares initially delivered to the Investor pursuant to Section 2.1(c)
is greater than the aggregate number of Shares to be purchased by the Investor pursuant to such Settlement Document, then, on the
Advance Shares True-Up Date, the Investor shall deliver to the Company any excess Estimated Advance Shares associated with such
requested Advance, unless the parties mutually agree for the Investor to retain such excess shares of Common Stock to apply to
the next requested Advance. If the number of Estimated Advance Shares initially delivered to the Investor pursuant to Section 2.1(c)
is less than the aggregate number of Shares to be purchased by the Investor pursuant to such Settlement Document, then, on the
Advance Shares True-Up Date, the Company shall deliver to the Investor a number of additional shares of the Company’s Common
stock equal to the difference between the Estimated Advance Shares and the Shares issuable pursuant to such Settlement Document.
In all circumstances any amount of additional shares due to the Investor to make up this difference on the Advance Share True-Up
Date shall not cause the Investor to exceed the Ownership Limitation. If the issuance of any such additional shares would cause
the Ownership Limitation or any other limitations set forth in Section 2.1(a) to be exceeded, then the amount of the Advance specified
in the Advance Notice shall be automatically reduced to an amount that would not cause any of such limitations to be exceeded,
and the amount of proceeds ultimately due to the Company will be reduced accordingly. The Closing of a request for an Advance shall
occur upon the date (the “Closing Date”) on which the settlement of trades of all of the Shares
that occurred during the applicable Pricing Period and after the applicable Advance Shares True-Up Date associated with such Advance
Notice in the Investor’s brokerage account has been completed and when any additional Shares, if required after an Advance
Share True-Up Date, have been deposited into the Investor’s brokerage account without restrictive legend and only after the
Investor’s broker has confirmed with the Investor that the Investor may execute trades with respect to any such additional
Advance Shares. A Closing may be delayed if Shares are sent via physical delivery in certificate form. In all circumstances no
subsequent Advance Notice(s) may be deemed delivered and the Investor has no obligation to accept subsequent Advance Notice(s)
until all shares of Common Stock related to a previous Advance Notice’s Advance Share True-Up Date have been deposited into
the Investor’s brokerage account without restrictive legend and only after the Investor’s broker has confirmed with
the Investor that the Investor may execute trades related to them. Once the settlement of all trades of all Shares has been confirmed
and, if applicable, any subsequent Shares due to the Investor have been received and their delivery and clearance in Investor’s
brokerage account confirmed, then the Investor shall confirm to the Company, by e-mail notification, that the Closing Date with
respect to the applicable Advance Notice has occurred, and within one (1) Trading Day of such confirmation, the Investor shall
deliver to the Company, by wire transfer of immediately available funds to an account designated in writing by the Company: (i)
the amount of the Advance specified in the Advance Notice, and as confirmed
and adjusted by the Settlement Document; less (ii) the Par Value Payment. In the event that the Investor is no longer able, due
to time constraints beyond its control, to perform a wire on any particular Trading Day, then the wire will be promptly executed
on the next following Trading Day. In lieu of delivering physical certificates representing the Common Stock issuable in accordance
with this Section 2.2(a), and provided that the Company’s transfer agent is then participating in the Depository Trust Company
(“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request of
the Investor, the Company shall cause the Company’s transfer agent to electronically transmit the applicable Shares by crediting
the account of the Investor’s prime broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”)
system, and provide proof satisfactory to the Investor of such delivery. No fractional shares shall be issued, and any fractional
amounts shall be rounded to the next higher whole number of Shares. Any certificates evidencing Shares delivered pursuant hereto
shall be free of restrictive legends.

 

    	7

    	 

    

 

(d)          Additional
Documents. On or prior to each Closing Date, each of the Company and the Investor shall deliver to the other all documents,
instruments and writings required to be delivered by either of them pursuant to this Agreement in order to implement and effect
the transactions contemplated herein.

 

(e)          Outstanding
Fees or Payments. To the extent the Company has not paid any fees, expenses, or other amounts due to the Investor in accordance
with this Agreement, then the amount of such fees, expenses, or other amounts due may be withheld by the Investor from the wire
transfer pursuant to that particular Advance Notice and used to pay for any such fees, expenses or other amounts due. If in the
event that on a Closing Date the amount of the requested Advance has been reduced to a dollar amount that does not exceed the initial
Par Value Payment made by the Investor, then that difference, up to the full Par Value Payment, will be required to be returned
and paid by the Company to the Investor on the next following Trading Day via wire transfer, if applicable. If there are any fees,
expenses, costs, or other amounts (including any portion of the Par Value Payment per the immediately preceding sentence) is due
by the Company to Investor, no subsequent Advance Notice(s) may be deemed delivered and the Investor has no obligation to accept
subsequent Advance Notice(s) if any such fees, expenses, costs, or other amounts (including any portion of the Par Value Payment
per the immediately preceding sentence) are then outstanding and due to the Investor.

 

(f)          Hardship.
In the event the Investor sells shares of the Company’s Common Stock after receipt of an Advance Notice and the Company
fails to perform its obligations as mandated in this Agreement, and specifically the Company fails to deliver to the Investor
the shares of Common Stock corresponding to the applicable Advance Notice pursuant to Sections 2.1 and 2.2 (including, without
limitation, delivery of any required Estimated Advance Shares and any additional Shares by no later than on the Advance Share
True-Up Date), the Company acknowledges that the Investor shall suffer financial hardship and therefore, the Company shall be
liable for any and all losses, commissions, fees, interest, legal fees or any other financial hardships caused to the Investor,
whether such hardships were caused by the Company’s failures, failures of the Company’s transfer agent, or otherwise.
As compensation to the Investor for late delivery of any such shares in accordance with the strict requirements of this Agreement,
the Company agrees to make payments to the Investor in accordance with the schedule below, such amounts being cumulative. The
Company understands that if for any reason shares of its Common Stock are not able to be delivered electronically, then significant
transaction delays may occur, impacting the ability of transfer agents, brokers, counterparties and intermediaries to deliver
and clear shares promptly. This may ultimately delay any applicable Advance Notice Date, Clearing Date, Advance Share True-Up
Date, and Closing Date related to an Advance Notice. Furthermore, the Company understands that additional costs may be associated
with the delivery of shares of its Common Stock when issued and/or delivered in certificate form and acknowledges that any related
fees will be borne by the Company in full. The Company shall pay any payments incurred under this Section in immediately available
funds upon demand. Nothing herein shall limit the right of the Investor to pursue all other remedies Investor may have, at law
or in equity, including, without limitation, specific performance or an injunction or injunctions to prevent such breaches of
this Agreement, without the posting of a bond or other security, for the Company’s failure to comply with the issuance and
delivery instructions and covenants set forth in this Agreement.

 

    	8

    	 

    

 

	Payments for Each Number of Days Overdue  	Fees for each $10,000 Worth of Common Stock
	 	 
	1	$ 100
	2	$200
	3	$300
	4	$400
	5	$500
	6	$600
	7	$700
	8	$800
	9	$900
	10	$1,000
	Over 10	$1,000 plus $200 for each Trading Day beyond the 10th day

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF INVESTOR

 

Investor hereby represents
and warrants to, and agrees with, the Company that the following are true and correct as of the Effective Date:

 

3.1           Organization
and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands
and has all requisite power and authority to purchase and hold the Shares. The decision to invest and the execution and delivery
of this Agreement by such Investor, the performance by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized and requires no other proceedings on the part of the
Investor. The undersigned has the right, power and authority to execute and deliver this Agreement and all other instruments on
behalf of the Investor. This Agreement has been duly executed and delivered by the Investor and, assuming the execution and delivery
hereof and acceptance thereof by the Company, will constitute the legal, valid and binding obligations of the Investor, enforceable
against the Investor in accordance with its terms.

 

3.2           Evaluation
of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an investment in the Company and of protecting its interests
in connection with this transaction. It recognizes that its investment
in the Company involves a high degree of risk.

 

    	9

    	 

    

 

 

3.3           Investment
Purpose. The securities are being purchased by the Investor for its own account, and for investment purposes. The Investor
agrees not to assign or in any way transfer the Investor’s rights to the securities or any interest therein and acknowledges
that the Company will not recognize any purported assignment or transfer except in accordance with applicable Federal and state
securities laws. No other person has or will have a direct or indirect beneficial interest in the securities. The Investor agrees
not to sell, hypothecate or otherwise transfer the Investor’s securities unless the securities are registered under Federal
and applicable state securities laws or unless, in the opinion of counsel satisfactory to the Company, an exemption from such
laws is available.

 

3.4           Investor
Status. The Investor is an “Accredited Investor” as that term is defined in
Rule 501(a)(3) of Regulation D of the Securities Act.

 

3.5           No
Legal Advice From the Company. The Investor acknowledges that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such
counsel and advisors and not on any statements or representations of the Company or any of the Company’s representatives
or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated by this Agreement
or the securities laws of any jurisdiction.

 

3.6           Not
an Affiliate. The Investor is not an officer, director or a Person that directly or indirectly, through one or more intermediaries,
controls or is controlled by, or is under common control with the Company or any Affiliate of the Company.

 

3.7           Trading
Activities. The Investor’s trading activities with respect to the Company’s Common Stock shall be in compliance
with all applicable federal and state securities laws, rules and regulations and the rules and regulations of the Principal
Market on which the Common Stock is listed or traded. Neither the Investor nor its Affiliates has an open short position in the
Common Stock, and the Investor agrees that it shall not, and that it will cause its Affiliates not to engage in any short sales
of the Common Stock during the Commitment Period; provided that the Company acknowledges and agrees that upon receipt of an Advance
Notice the Investor has the right to sell the Shares to be issued to the Investor pursuant to the Advance Notice prior to receiving
such Shares, subject to the limitations set forth in this Section.

 

    	10

    	 

    

 

 

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE
COMPANY

 

Except as stated below,
on the disclosure schedules attached hereto, if any, the Company hereby represents and warrants to the Investor that the following
are true and correct as of the Effective Date:

 

4.1          Due
Diligence Documents; Financial Statements. The Company is a non-reporting Company with the SEC and the Company’s Common Stock
is currently not registered pursuant to Section 12 of the Exchange Act, and as of the date hereof, the Company is not required
to file, and has not filed, any periodic reports with the SEC under Sections 13 or 15(d) of the Exchange Act. The Company, however, has delivered certain reports, schedules, forms, statements and other due diligence documents and materials to Investor (referred
to as the “Due Diligence Materials”). The Company shall also deliver to Investor true and complete copies
of all draft filings, reports, schedules, statements and other documents voluntarily filed or required to be filed by the Company
under the Exchange Act, any rules of any Principal Market, or any other applicable Law that have been prepared but not filed as
of the date hereof. None of the Due Diligence Materials contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements or information therein, in light of the circumstances
under which they were made, not misleading. In addition, the Company has delivered to Investor unaudited financial statements,
including Statement of Income, Balance Sheet and Statement of Cash Flows for fiscal year ending December 31, 2011, as well as unaudited
financial statements, including Statement of Income, Balance Sheet and Statement of Cash Flows for fiscal quarter ending March
31, 2012 and fiscal quarter ending June 30, 2012 (collectively, the “Financial Statements”). All
of the Financial Statements have been prepared in accordance with GAAP, consistently applied, during the periods involved (except:
(i) as may be otherwise indicated in such Financial Statements or the notes thereto; or (ii) in the case of unaudited interim statements,
to the extent they may exclude footnotes or may be condensed or summary statements), and fairly present in all material respects
the consolidated financial position of the Company and its subsidiaries as of the dates thereof and the consolidated results of
its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments). In addition, the Company represents and warrants that it has engaged a PCAOB approved and registered accounting firm
(the “Accounting Firm”) that has prepared audited financial statements for the Company (which financial
statements are approximately 90% completed as of the date hereof) (the “Audited Financials”) that comply
with in all material respects with applicable accounting requirements and the published rules and regulations of the SEC and the
Principal Market with respect thereto. The Company further represents and warrants the it has paid (or will be paying simultaneously
with the execution of this Agreement) the Accounting Firm preparing the Audited Financials in full for all work associated with
the production and completion of the Audited Financials.

 

4.2           Organization
and Qualification. The Company is duly incorporated, validly existing and in good standing under the laws of the jurisdiction
of its incorporation and has all requisite corporate power to own its properties and to carry on its business as now being conducted.
Each of the Company and its subsidiaries is duly qualified as a foreign corporation to do business and is in good standing in every
jurisdiction in which the nature of the business conducted by it makes such qualification necessary, except to the extent that
the failure to be so qualified or be in good standing would not have a Material Adverse Effect.

 

4.3           Authorization,
Enforcement, Compliance with Other Instruments. (i) The Company has the requisite corporate power and authority to enter into
and perform this Agreement and any related agreements, in accordance with the terms hereof and thereof; (ii) the execution and
delivery of this Agreement and any related agreements by the Company and the consummation by it of the transactions contemplated
hereby and thereby, have been duly authorized by the Company’s Board of Directors and no further consent or authorization is required
by the Company, its Board of Directors or its stockholders; (iii) this Agreement and any
related agreements have been duly executed and delivered by the Company; (iv) this Agreement
and assuming the execution and delivery thereof and acceptance by the Investor, any related agreements, constitute the valid and
binding obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies.

 

    	11

    	 

    

 

4.4           Capitalization.
The authorized capital stock of the Company consists of 34,000,000 shares of Common Stock, and 1,000,000 shares of the Company’s
preferred stock, $0.0001 par value per share (the “Preferred Stock”). The Company has 19,069,122 shares
of Common Stock issued and outstanding as of the Effective Date, and 210,000 shares of Preferred Stock issued and outstanding as
of the Effective Date (100,000 shares of Series A Preferred Stock and 110,000 shares of Series D Preferred Stock). All of such
outstanding shares have been validly issued and are fully paid and nonassessable. The Common Stock is currently quoted on the OTC
Pink Sheets under the trading symbol “MHCC.” No shares of Common Stock are subject to preemptive rights or any other
similar rights or any liens or encumbrances suffered or permitted by the Company. As of the date hereof: (i) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, any shares of capital stock of the Company or any of its subsidiaries, or contracts, commitments, understandings
or arrangements by which the Company or any of its subsidiaries is or may become bound to issue additional shares of capital stock
of the Company or any of its subsidiaries, or options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its subsidiaries;
(ii) there are no outstanding debt securities; (iii) there are no outstanding registration statements; and (iv) there are no agreements
or arrangements under which the Company or any of its subsidiaries is obligated to register the sale of any of their securities
under the Securities Act (except pursuant to this Agreement). There are no securities or instruments containing anti-dilution or
similar provisions that will be triggered by this Agreement or any related agreement or the consummation of the transactions described
herein or therein. The Company has furnished or made available to the Investor true and correct copies of the Company’s Certificate
of Incorporation, as amended and as in effect on the date hereof (the “Certificate of Incorporation”),
and the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities
convertible into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.

 

4.5           No
Conflict. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby will not: (i) result in a violation of the Certificate of Incorporation, any certificate of designations
of any outstanding series of Preferred Stock of the Company or By-laws; or (ii) conflict with or constitute a default (or an event
which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its subsidiaries is a party,
or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and
regulations and the rules and regulations of the Principal Market on which the Common Stock is quoted) applicable to the Company
or any of its subsidiaries or by which any material property or asset of the Company is bound or affected and which would cause
a Material Adverse Effect. Neither the Company nor its subsidiaries is in violation of any term of or in default under its Certificate
of Incorporation or By-laws or their organizational charter or by-laws, respectively, or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or regulation applicable to the Company or
its subsidiaries that would cause a Material Adverse Effect. The business of the Company and its subsidiaries is not being conducted
in violation of any material law, ordinance or regulation of any governmental entity. Except as specifically contemplated by this
Agreement and as required under the Securities Act and any applicable state securities laws, the Company is not required to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for
it to execute, deliver or perform any of its obligations under or contemplated by this Agreement in accordance with the terms hereof
or thereof. All consents, authorization, orders, filings and registrations which the Company is required to make or obtain pursuant
to the preceding sentence have been obtained or effected on or prior to the date hereof. The Company and its subsidiaries are not
aware of any fact or circumstance which might give rise to any of the foregoing.

 

    	12

    	 

    

 

4.6           No
Default. The Company is not in default in the performance or observance of any material obligation, agreement, covenant or
condition contained in any indenture, mortgage, deed of trust or other material instrument or agreement to which it is a party
or by which it is or its property is bound, and neither the execution, nor the delivery by the Company, nor the performance by
the Company of its obligations under this Agreement or any of the exhibits or attachments hereto, will conflict with or result
in the breach or violation of any of the terms or provisions of, or constitute a default or result in the creation or imposition
of any lien or charge on any assets or properties of the Company, under its Certificate of Incorporation, By-Laws, any material
indenture, mortgage, deed of trust or other material agreement applicable to the Company or instrument to which the Company is
a party or by which it is bound, or any statute, or any decree, judgment, order, rules or regulation of any court or governmental
agency or body having jurisdiction over the Company or its properties, in each case which default, lien or charge is likely to
cause a Material Adverse Effect.

 

4.7           Intellectual
Property Rights. The Company and its subsidiaries own or possess adequate rights or licenses to use all material trademarks,
trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted.
The Company and its subsidiaries do not have any knowledge of any infringement by the Company or its subsidiaries of trademark,
trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations,
trade secret or other similar rights of others, and, to the knowledge of the Company, there is no claim, action or proceeding being
made or brought against, or to the Company’s knowledge, being threatened against the Company or its subsidiaries, regarding trademark,
trade name, patents, patent rights, invention, copyright, license, service names, service marks, service mark registrations, trade
secret or other infringement; and the Company is not aware of any facts or circumstances which might give rise to any of the foregoing.

 

4.8           Employee
Relations. Neither the Company nor any of its subsidiaries is involved in any labor dispute nor, to the knowledge of the Company
or any of its subsidiaries, is any such dispute threatened. None of the Company’s or its subsidiaries’ employees is a member of
a union and the Company and its subsidiaries believe that their relations with their employees are good.

 

4.9           Environmental
Laws. The Company and its subsidiaries are: (i) in compliance with any and all applicable material foreign, federal, state
and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances
or wastes, pollutants or contaminants (“Environmental Laws”); (ii) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii)
are in compliance with all terms and conditions of any such permit, license or approval, in each case except where such noncompliance
or nonreceipt would not, individually or in the aggregate, have a Material Adverse Effect.

 

4.10       Title. The Company has good and marketable title to
its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable
interest, other than such as are not material to the business of the Company. Any real property and facilities held under lease
by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are
not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its
subsidiaries.

  

    	13

    	 

    

 

4.11        Insurance. The Company and each of its subsidiaries
are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as
management of the Company believes to be prudent and customary for similarly situated companies in the businesses in which
the Company and its subsidiaries are engaged. The Company has not been refused any insurance coverage sought or applied for
and the Company does not have any reason to believe that it will not be able to renew its existing insurance coverage as
and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its
business at a cost that would not have a Material Adverse Effect.

 

4.12        Regulatory Permits. The Company and its subsidiaries possess all material certificates,
authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct
their respective businesses, and neither the Company nor any such subsidiary has received any notice of proceedings relating
to the revocation or modification of any such certificate, authorization or permit.

 

4.13 
      Internal Accounting Controls. The Company and each of its subsidiaries maintain a
system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in
accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.

 

4.14        No
Material Adverse Breaches, etc. Neither the Company nor any of its subsidiaries is subject to any charter, corporate or other
legal restriction, or any judgment, decree, order, rule or regulation which, in the judgment of the Company’s officers,
has or is expected in the future to have a Material Adverse Effect on the Company or its subsidiaries, taken as a whole.

 

4.15        Absence of Litigation. There is no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency, self-regulatory organization or body pending against
or affecting the Company, the Common Stock or any of the Company’s subsidiaries, wherein an unfavorable decision,
ruling or finding would have a Material Adverse Effect.

 

4.16        Subsidiaries.
Except for one hundred percent (100%) ownership of each of Millennium ProComm Solutions, Inc., a New York corporation,
Millennium Coding & Billing, Inc., a New York corporation, Millennium Medical Devices, LLC, a New York limited liability
company, Millennium Vascular Management Group, Inc., a New York corporation, and Millennium Vascular Management Group of
Staten Island, LLC, a New York limited liability company, the Company does not own, directly or indirectly, any outstanding
voting securities of or other interests in, or have any control over, any other Person.

 

4.17         Tax
Status. The Company and each of its subsidiaries has made or filed all foreign, federal and state income and all other tax
returns, reports and declarations required by any jurisdiction to which it is subject and (unless and only to the extent that the
Company and each of its subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and
unreported taxes) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations, except those being contested in good faith, and the Company and its subsidiaries
have set aside on their respective books provision reasonably adequate for the payment of all taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.

 

    	14

    	 

    

 

4.18         Certain
Transactions. None of the officers, directors, or employees of the Company is presently a party to any transaction with the
Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust
or other entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee
or partner.

 

4.19         The
Shares. The Shares have been duly authorized and, when issued, delivered and paid for pursuant to this Agreement, will be validly
issued and fully paid and non-assessable, free and clear of all liens, claims and encumbrances of any nature or kind, and will
be issued in compliance with all applicable United States federal and state securities laws. The capital stock of the Company,
including the Common Stock, shall confirm in all material respects to the description thereof to be contained in the Registration
Statement. Neither the stockholders of the Company, nor any other Person, have any preemptive rights or rights of first refusal
with respect to the Shares or other rights to purchase or receive any of the Shares or any other securities or assets of the Company,
and no Person has the right, contractual or otherwise, to cause the Company to issue to it, or register pursuant to the Securities
Act, any shares of capital stock or other securities or assets of the Company upon the issuance or sale of the Shares. The Company
is not obligated to offer the Shares on a right of first refusal basis or otherwise to any third parties including, without limitation,
to current or former shareholders of the Company, underwriters, brokers, or agents.

 

4.20         Dilution.
The Company is aware and acknowledges that issuance of the Shares could cause dilution to existing shareholders and could significantly
increase the outstanding number of shares of Common Stock.

 

4.21         Acknowledgment
Regard ing Investor’s Purchase of Shares. The Company acknowledges and agrees that the Investor is acting solely in the capacity
of an arm’s length investor with respect to this Agreement and the transactions contemplated hereunder. The Company further acknowledges
that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to
this Agreement and the transactions contem plated hereunder and any advice given by the Investor or any of its representatives
or agents in connection with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s
purchase of the Shares hereunder. The Company is aware and acknowledges that it may not be able to request Advances under this
Agreement until a Registration Statement becomes effective, and only in compliance with the rules of the Principal Market. The
Company further is aware and acknowledges that any fees paid or shares issued pursuant to Section 12.4 hereunder shall be earned
as of the Effective Date and are not refundable or returnable under any circumstances.

  

    	15

    	 

    

 

ARTICLE V

INDEMNIFICATION

 

The Investor and the Company
covenant to the other the following with respect to itself:

 

5.1          Indemnification
by the Company. In consideration of the Investor’s execution and delivery of this Agreement, and in addition to all
of the Company’s other obligations under this Agreement, the Company shall, and does hereby agree to, defend, protect, indemnify
and hold harmless the Investor, and all of the Investor’s affiliates and subsidiaries, and each Person who controls the
Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the officers, directors,
partners, members, employees and agents of each of them (collectively, the “Investor Indemnitees”),
from and against any and all actions, causes of action, suits, claims, demands, threats and proceedings (collectively, the “Claims”),
and the Company agrees to reimburse the Investor Indemnitees, or any of them, for any and all losses, costs, penalties, fees,
liabilities, obligations, judgments, expenses, and damages, including, without limitation, reasonable attorneys’ fees, paralegals’
fees and other costs, expenses and disbursements reasonably incurred by the Investor Indemnities, or any of them, in connection
with investigating, defending or settling any such Claims, including such expenses incurred throughout all trial and appellate
levels and administrative and bankruptcy proceedings (collectively, the “Indemnified Liabilities”),
suffered or incurred by the Investor Indemnitees, or any of them, as a result of, or arising out of, or relating to: (a) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares
as originally filed or in any amendment thereof, or in any related prospectus, or in supplement, or in any amendment thereof or
supplement thereto, or arising out of or which are based upon the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the Company
will not be liable in any such case to the extent that any such Indemnified Liabilities arise out of or are based upon any such
untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with
written information furnished to the Company by or on behalf of the Investor specifically for inclusion therein; (b)   
any misrepresentation or breach of any representation or warranty made by the Company in this Agreement or any other certificate,
instrument or document contemplated hereby or thereby; (c) any breach of any covenant, agreement or obligation of the Company
contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby; and (d) any Claim
brought or made against the Investor Indemnitees, or any of them, not arising out of any action or inaction of an Investor Indemnitee,
and arising out of or resulting from the execution, delivery, performance or enforcement of this Agreement or any other instrument,
document or agreement executed pursuant hereto or thereto by any of the Investor Indemnitees. To the extent that the foregoing
undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment
and satisfaction of each of the Indemnified Liabilities, which is permissible under applicable law.

 

    	16

    	 

    

 

5.2           Indemnification
by Investor. In consideration of the Company’s execution and delivery of this Agreement, and in addition to all of the Investor’s other obligations under this Agreement, the Investor shall, and does hereby agree to, defend, protect, indemnify and hold harmless
the Company, and all of the Company’s subsidiaries, and each Person who controls the Company with in the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act, and the officers, directors, partners, members, employees and agents of
each of them (collectively, the “Company Indemnitees”), from and against any and all Claims, and the Investor
agrees to reimburse the Company Indemnitees, or any of them, for any and all Indemnified Liabilities, suffered or incurred by the
Company Indemnitees, or any of them, as a result of, or arising out of, or relating to: (a) any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or
in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arising out of or
which are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, but only to the extent that any such untrue statement or alleged untrue statement
or omission or alleged omission was in connection with information furnished to the Company by Investor specifically for inclusion
therein; provided, however, that the Investor will not be liable in any such case to the extent that any such Indemnified
Liabilities arise out of or are based upon any such untrue statement or alleged untrue statement or omission or alleged omission
made therein by the Company; (b) any misrepresentation or breach of any representation or warranty made by the Investor in this
Agreement or any other certificate, instrument or document contemplated hereby or thereby; (c) any breach of any covenant, agreement
or obligation of the Investor contained in this Agreement or any other certificate, instrument or document contemplated hereby
or thereby; and (d) any Claim brought or made against the Company Indemnitees, or any of them, not arising out of any action or
inaction of a Company Indemnitee, and arising out of or resulting from the execution, delivery, performance or enforcement of this
Agreement or any other instrument, document or agreement executed pursuant hereto or thereto by any of the Company Indemnitees.
To the extent that the foregoing undertaking by the Investor may be unenforceable for any reason, the Investor shall make the
maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under applicable
law.

 

5.3           Notice
of Claim. For purposes of this Article V, a party that is subject to a Claim and entitled to indemnification hereunder
is sometimes hereinafter referred to as the “lndemnitee,” and the party having the obligation to
indemnify the other is sometimes hereinafter referred to as the “Indemnitor.” Promptly after
receipt by an Indemnitee of notice of the commencement of any Claim involving an Indemnified Liability, such Indemnitee
shall, if an Indemnified Liability in respect thereof is to be made against any Indemnitor, deliver to the Indemnitor a
written notice of the commencement thereof; provided, however, that the failure to so notify the Indemnitor: (i) will not
relieve the Indemnitor of liability under this Article V, unless and to the extent the Indemnitor did not otherwise learn of
such Claim and such failure results in the forfeiture by the Indemnitor of substantial rights and defenses; and (ii) will
not, in any event, relieve the Indemnitor from any obligations to the Indemnitee, other than those indemnity obligations
provided in this Article V. In the case of parties indemnified pursuant to Section 5.1 above, counsel to the Indemnitee shall
be selected by the Company, and, in the case of parties indemnified pursuant to Section 5.2 above, counsel to the Indemnitee
shall be selected by the Investor. An Indemnitor may participate, at its own expense, in the defense of any such Claim;
provided, however, that counsel to the Indemnitor shall not (except with the consent of the Indemnitee) also be counsel to
the Indemnitee. In no event shall the Indemnitor be liable for fees and expenses of more than one counsel (in addition to any
local counsel) separate from their own counsel for all Indemnitees in connection with any one action or separate but similar
or related actions in the same jurisdiction arising out of the same general allegations or circumstances. The Indemnitee
shall cooperate fully with the Indemnitor in connection with any negotiation or defense of any Claim, and the
Indemnitee shall furnish to the Indemnitor all information reasonably available to the Indemnitee which relates to such
Claim. The Indemnitor shall keep the Indemnitee fully apprised at all times as to the status of the defense or any settlement
negotiations with respect thereto. An Indemnitor will not, without the prior written consent of the Indemnitee, settle or
compromise or consent to the entry of any judgment with respect to any pending or threatened Claim in respect of which
indemnification or contribution may be sought under this Agreement (whether or not the Indemnitees are actual or potential
parties to such Claim) unless: (i) such settlement, compromise or consent includes an unconditional release of each
Indemnitee from all liability arising out of such Claim; and (ii ) such settlement, compromise or consent does not include a
statement as to or an admission of fault, culpability or a failure to act by or on behalf of any Indemnitee. Following
indemnification as provided for hereunder, the Indemnitor shall be subrogated to all rights of the Indemnitee with respect to
all third parties, firms or corporations relating to the matter for which indemnification has been made.

 

    	17

    	 

    

 

5.4           Contribution.
In the event that the indemnity provided in Section 5.1 or Section 5.2 is unavailable to or insufficient to hold harmless an
Indemnitee for any reason, the Company and the Investor, as applicable, severally agree to contribute to the aggregate
Indemnified Liabilities to which the Company and the Investor may be subject, as applicable, in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand and by the Investor on the other from
transactions contemplated by this Agreement. If the allocation provided by the immediately preceding sentence is unavailable
for any reason, the Company and the Investor severally shall contribute in such proportion as is appropriate to reflect not
only such relative benefits but also the relative fault of the Company on the one hand and of the Investor on the other in
connection with the statements or omissions which resulted in such Indemnified Liabilities as well as any other relevant
equitable considerations. Benefits received by the Company shall be deemed to be equal to the total proceeds from the
offering (net of underwriting discounts and commissions but before deducting expenses) received by it, and benefits received
by the Investor shall be deemed to be equal to the total discounts received by the Investor. Relative fault shall be
determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information provided by the Company on the one hand or the
Investor on the other, the intent of the parties and their relative knowledge, access to information and opportunity to
correct or prevent such untrue statement or omission. The Company and the Investor agree that it would not be just and
equitable if contribution were determined by pro rata allocation or any other method of allocation which does not
take account of the equitable considerations referred to above. The aggregate amount of Indemnified Liabilities incurred by
an Indemnitee and referred to above in this Article V shall be deemed to include any legal or other expenses reasonably
incurred by such Indemnitee in investigating, preparing or defending against any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or
alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section 5.4, the Investor
shall not be required to contribute any amount in excess of the amount by which the Purchase Price for Shares actually
purchased pursuant to this Agreement exceeds the amount of any damages which the Investor has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent
misrepresentation (within the meaning of Section ll(f) of the Securities Act) shall be entitled to contribution from any
Person who was not guilty of such fraudulent misrepresentation. For purposes of this Article V, each Person who controls the
Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and each director, officer,
employee and agent of the Investor shall have the same rights to contribution as the Investor, and each Person who controls
the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, each officer of the
Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to
contribution as the Company, subject in each case to the applicable terms and conditions of this Section 5.4.

 

5.5           Remedies.
The remedies provided for in this Article V are not exclusive and shall not limit any rights or remedies which may otherwise be
available to any Indemnitee.

 

5.6           Survival.
The obligations of the parties to indemnify or make contribution under this Article V shall survive termination of this Agreement.

 

    	18

    	 

    

 

ARTICLE VI

COVENANTS OF THE
COMPANY

 

6.1           Registration
Rights. The Company shall cause the Registration Rights Agreement to remain in full force and effect and the Company shall
comply in all material respects with the terms thereof.

 

6.2           Listing
of Common Stock. The Company shall maintain the Common Stock’s authorization for quotation on a Principal Market, including
the OTC Markets.

 

6.3           Exchange
Act Registration. The Company shall, within forty-five (45) days from the Effective Date (the “Reporting Date”):
(i) provide and deliver to Buyer a complete copy of the Audited Financials containing an unqualified opinion of the Accounting
Firm; and (ii) file a Form 10 and comply with any other requirements to become a full reporting Company required to file reports
with the SEC under the Exchange Act, and have its Common Stock registered with the SEC under Section 12
of the Exchange Act, and provide to Buyer evidence reasonably acceptable to the Buyer of same. In addition, immediately
after the Form 10 becomes effective with the SEC, but in no event later than sixty (60) days after the Reporting Date, the Company
shall file all required applications and documents to have its Common Stock quoted and listed in the OTC Bulletin Board, which
shall be the Company’s Principal Market. In that regard, the Company shall file all required applications, reports, statements
and all other documents, and pay all required fees and costs, necessary or required in order for the Company to accomplish the
foregoing requirements. From and after the Reporting Date, the Company will cause its Common Stock to continue to be registered
under the Exchange Act. In addition, within sixty (60) days after the Reporting Date, the Company will file in a timely manner
all reports and other documents required of it as a reporting company under the Exchange Act and will not take any action or file
any document (whether or not permitted by Exchange Act or the rules thereunder) to terminate or suspend such registration or to
terminate or suspend its reporting and filing obligations under said Exchange Act.

 

6.4           Transfer
Agent Instructions. Not later than two (2) business days after each Advance Notice Date and prior to each Closing and the
effectiveness of the Registration Statement and resale of the Common Stock by the Investor, the Company will deliver instructions
to its transfer agent to issue shares of Common Stock free of restrictive legends.

 

6.5           Corporate
Existence. The Company will take all steps necessary to preserve and continue the corporate existence of the Company.

 

6.6           Notice
of Certain Events Affecting Registration; Suspension of Right to Make an Advance. The Company will immediately notify the Investor
upon its becoming aware of the occurrence of any of the following events in respect of a Registration Statement or related prospectus
relating to an offering of Registrable Securities: (i) receipt of any request for additional information by the SEC or any other
Federal or state governmental authority, during the period of effectiveness of the Registration Statement, for amendments or supplements
to the Registration Statement or related prospectus; (ii) the issuance by the SEC or any other Federal or state governmental authority
of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose;
(iii) receipt of any notification with respect to the suspension of the qualification or exemption from qualification of any of
the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv)
the happening of any event that makes any statement made in the Registration Statement or related prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in
the Registration Statement, related prospectus or such other documents so that, in the case of the Registration Statement, it will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and (v) the Company’s reasonable determination that
a post-effective amendment to the Registration Statement would be appropriate, in which event the Company will promptly make available
to the Investor any such supplement or amendment to the Registration Statement and related prospectus. The Company shall not deliver
to the Investor any Advance Notice during the continuation of any of the foregoing events.

 

    	19

    	 

    

 

6.7           Expectations
Regarding Advance Notices. Within ten (10) days after the commencement of each calendar quarter occurring subsequent to the
commencement of the Commitment Period, the Company must notify the Investor, in writing, as to its reasonable expectations as to
the dollar amount it intends to raise during such calendar quarter, if any, through the issuance of Advance Notices. Such notification
shall constitute only the Company’s good faith estimate and shall in no way obligate the Company to raise such amount, or any amount,
or otherwise limit its ability to deliver Advance Notices.

 

6.8           Intentionally
Deleted.

 

6.9           Consolidation;
Merger. The Company shall not, at any time after the Effective Date, effect any merger or consolidation of the Company with
or into, or a transfer of all or substantially all the assets of the Company to, another entity (a “Consolidation
Event”), unless the resulting successor or acquiring entity (if not the Company) assumes by written instrument the
obligation to deliver to the Investor such shares of stock and/or securities as the Investor is entitled to receive pursuant to
this Agreement.

 

6.10         Issuance
of the Company’s Common Stock. The sale of the shares of Common Stock by the Company to the Investor hereunder shall be made
in accordance with the provisions and requirements of the Securities Act and Regulation D and any applicable state securities law.

 

6.11         Expenses.
The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay all
expenses incident to the performance of its obligations hereunder, including, without limitation: (i) the preparation, printing
and filing of the Registration Statement and each amendment and supplement thereto, of each related prospectus and of each amendment
and supplement thereto; (ii) the preparation, issuance and delivery of any Shares issued pursuant to this Agreement; (iii) all
fees and disbursements of the Company’s counsel, accountants and other advisors; (iv) the qualification of the Shares under securities
laws in accordance with the provisions of this Agreement, including filing fees in connection therewith; (v) the fees and expenses
incurred in connection with the listing or qualification of the Shares for trading on the Principal Market; or (vi) filing fees
of the SEC, the Principal Market and any other regulatory or governmental body or authority.

 

6.12         Compliance
with Laws. The Company will not, directly or indirectly, take any action designed to cause or result in, or that constitutes
or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company or
which caused or resulted in, or which would in the future reasonably be expected to cause or result in, stabilization or manipulation
of the price of any security of the Company.

 

    	20

    	 

    

 

6.13         Opinion
of Counsel. Prior to the date of the first Advance Notice, the Investor shall have received an opinion letter from counsel
to the Company reasonably acceptable to the Investor, containing, at a minimum, the opinions set forth in Exhibit “C”
attached hereto.

 

6.14         Review
of Public Disclosures. None of the public disclosures made by the Company, including, without limitation, press releases, investor
relations materials, and scripts of analysts meetings and calls will contain any untrue statements of material fact, nor will they
omit to state any material fact required to be stated therein necessary to make the statements made in light of the circumstances
under which they were made, not misleading.

 

6.15         Opinion
of Counsel Concerning Resales. Provided that the Investor’s resale of Common Stock received pursuant to this Agreement may
be freely sold by the Investor either pursuant to an effective Registration Statement, in accordance with Rule 144, or otherwise,
the Company shall obtain for the Investor, at the Company’s expense, any and all opinions of counsel which may be required by
the Company’s transfer agent to issue such shares free of restrictive legends, or to remove legends from such shares.

 

6.16         Sales.
Without the written consent of the Investor, the Company will not, directly or indirectly, offer to sell, sell, contract to sell,
grant any option to sell or otherwise dispose of any shares of Common Stock (other than the Shares offered pursuant to the provisions
of this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire
Common Stock, during the period beginning on the 5th Trading Day immediately prior to an Advance Notice Date and ending on the
2nd Trading Day immediately following the corresponding Closing Date.

 

6.17         Insider
Trading. Notwithstanding any other provision of this Agreement, the Company shall not deliver an Advance Notice during any
period in which the Investor is in possession of material non -public information.

 

ARTICLE VII

CONDITIONS FOR ADVANCE AND CONDITIONS
FOR CLOSING

 

The right of the
Company to deliver an Advance Notice and the obligations of the Investor hereunder to acquire Shares and pay for Shares of the
Company’s Common Stock is subject to the satisfaction by the Company, on each Advance Notice Date and on each Closing Date (a “Condition
Satisfaction Date”), of each of the following conditions:

 

7.1           Accuracy
of the Company’s Representations and Warranties. The representations and warranties of the Company shall be true and correct
in all material respects.

 

7.2           Registration
of the Common Stock with the SEC. The Company shall have filed with the SEC a Registration Statement with respect to the resale
of the Registrable Securities in accordance with the terms of the Registration Rights Agreement. As set forth in the Registration
Rights Agreement, the Registration Statement shall have been declared effective by the SEC and shall remain effective on each Condition
Satisfaction Date, and: (i) neither the Company nor the Investor shall have received notice that the SEC has issued or intends
to issue a stop order with respect to the Registration Statement, or that the
SEC otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently,
or intends or has threatened to do so (unless the SEC’s concerns have been addressed and the Investor is satisfied, in its sole
discretion, that the SEC no longer is considering or intends to take such action); and (ii) no other suspension of the use or
withdrawal of the effectiveness of the Registration Statement or related prospectus shall exist. The Registration Statement must
have been declared effective by the SEC prior to the first Advance Notice Date.

 

    	21

    	 

    

  

7.3          Authority.
The Company shall have obtained all permits and qualifications required by any applicable state for the offer and sale of the
Shares, or shall have the availability of exemptions therefrom. The sale and issuance of the Shares shall be legally permitted
by all laws and regulations to which the Company is subject.

 

7.4          No
Material Notices. None of the following events shall have occurred and be continuing: (i) receipt by the Company of any request
for additional information from the SEC or any other federal or state governmental, administrative or self regulatory authority
during the period of effectiveness of the Registration Statement, the response to which would require any amendments or supplements
to the Registration Statement or related prospectus; (ii) the issuance by the SEC or any other federal or state governmental authority
of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose;
(iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification
of any of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the
occurrence of any event that makes any statement made in the Registration Statement or related prospectus, or any document incorporated
or deemed to be incorporated therein by reference, untrue in any material respect or that requires the making of any changes in
the Registration Statement, related Prospectus or documents so that, in the case of the Registration Statement, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under and as of the date which they were made, not misleading; and (v) the Company’s reasonable
determination that a post effective amendment to the Registration Statement would be required. 

 

7.5          Fundamental
Changes. There shall not exist any fundamental changes to the information set forth in the Registration Statement which would
require the Company to file a post effective amendment to the Registration Statement.

 

7.6          Performance
by the Company. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Agreement, or any other agreements between the Company and Investor, to be performed, satisfied
or complied with by the Company at or prior to each Condition Satisfaction Date.

 

7.7          No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits or directly and adversely
affects any of the transactions contemplated by this Agreement, and no proceeding shall have been commenced that may have a Material
Adverse Effect.

 

    	22

    	 

    

 

7.8          No
Suspension of Trading in or Delisting of Common Stock.  The Common Stock is trading on the OTC Bulletin Board as
its Principal Market (or other Principal Market acceptable to Investor in its sole discretion) and all of the Shares issuable
pursuant to such Advance Notice will be listed or quoted for trading on such Principal Market and the Investor believes, in good
faith, that trading of the Common Stock on a Principal Market will continue uninterrupted for the foreseeable future. The issuance
of Shares with respect to the applicable Advance Notice will not violate the shareholder approval requirements of the Principal
Market. The Company shall not have received any notice threatening the continued listing of the Common Stock on the Principal
Market.

 

7.9         Authorized.
There shall be a sufficient number of authorized but unissued and otherwise unreserved shares of Common Stock for the issuance
of all of the Shares issuable pursuant to such Advance Notice.

 

7.10       Executed
Advance Notice.  The Investor shall have received the Advance Notice executed by an officer of the Company and the
representations contained in such Advance Notice shall be true and correct as of each Condition Satisfaction Date.

 

7.11      Consecutive Advance Notices.  Except with respect to the first Advance Notice,
the Company shall have delivered all Shares relating to all prior Advances.

 

7.12       No
Material Adverse Effect. No event shall have occurred which could reasonably be expected to have a Material Adverse Effect.

 

7.13       Adverse
Effect of Price or Volume. No event shall have occurred that would have a material adverse effect on the price or trading
volume of the Company’s Common Stock, or the Investor’s ability to sell Shares in the Principal Market in the manner intended
by this Agreement, as determined by Investor in its sole discretion.

 

ARTICLE
VIII

DUE
DILIGENCE REVIEW; NON-DISCLOSURE OF NON-PUBLIC INFORMATION

 

8.1          Due
Diligence Review. Prior to the filing of the Registration Statement, the Company shall make available for inspection and review
by the Investor, advisors to and representatives of the Investor and any underwriter participating in any disposition of the Registrable
Securities on behalf of the Investor pursuant to the Registration Statement, any such Registration Statement or amendment or supplement
thereto, or any blue sky, NASD, FINRA, or other filing, all financial and other records, all filings with the SEC, and all other
corporate documents and properties of the Company as may be reasonably necessary or required by the Investor and any such advisors,
representatives and underwriters, and cause the Company’s officers, directors and employees to supply all such information requested
by the Investor or any such representative, advisor or underwriter in connection with such Registration Statement (including,
without limitation, in response to all questions and other inquiries reasonably made or submitted by any of them), prior to and
from time to time after the filing and effectiveness of the Registration Statement, for the sole purpose of enabling the Investor
and such representatives, advisors and underwriters and their respective accountants and attorneys to conduct initial and ongoing
due diligence with respect to the Company and the accuracy of the Registration Statement.

 

    	23

    	 

    

 

8.2          Company
Non-Public Information.

 

(a)          Nothing
herein shall require the Company to disclose non-public information to the Investor or its advisors or representatives, unless
prior to disclosure of such information, the Company identifies such information as being non-public information and provides
the Investor, such advisors and representatives with the opportunity to accept or refuse to accept such non -public information
for review. The Company may, as a condition to disclosing any non-public information hereunder, require the Investor and its advisors
and representatives to enter into a confidentiality agreement inform reasonably satisfactory to the Company and the Investor.
Notwithstanding anything contained in this Agreement or the Registration Rights Agreement to the contrary, the Company shall not
deliver material, non-public information to the Investor during the time when an Advance Notice is outstanding.

 

(b)          The
Company represents that it does not disseminate non -public in formation in violation of the Exchange Act or Securities Act to
any investors who purchase stock in the Company in a public offering, to money managers or to securities analysts, provided, however,
that notwithstanding anything herein to the contrary, the Company will immediately notify the advisors and representatives of
the Investor and, if any, underwriters, of any event or the existence of any circumstance (without any obligation to disclose
the specific event or circumstance) of which it becomes aware, constituting non public information (whether or not requested of
the Company specifically or generally during the course of due diligence by such persons or entities), which, if not disclosed
in the prospectus included in the Registration Statement would cause such prospectus to include a material misstatement or to
omit a material fact required to be stated therein in order to make the statements therein, in light of the circumstances in
which they were made, not misleading. Nothing contained in this Article VIII shall be construed to mean that such persons or entities
other than the Investor (without the written consent of the Investor prior to disclosure of such information) may not obtain non
-public information in the course of conducting due diligence in accordance with the terms of this Agreement and nothing herein
shall prevent any such persons or entities from notifying the Company of their opinion that based on such due diligence by such
persons or entities, that the Registration Statement contains an untrue statement of material fact or omits a material fact required
to be stated in the Registration Statement or necessary to make the statements contained therein, in light of the circumstances
in which they were made, not misleading.

 

ARTICLE
IX

CHOICE
OF LAW/JURISDICTION

 

This
Agreement shall be governed by and interpreted in accordance with the laws of the State of Nevada, without regard to the principles
of conflict of laws. The parties further agree that any action between them shall be heard in a federal or state court in Clark
County, Nevada, and expressly consent to the jurisdiction and venue of the state courts sitting in Clark County, Nevada and the
United States District Court for the District of Nevada, for the adjudication of any civil action asserted pursuant to this paragraph; provided, however, nothing contained herein shall limit the Investor’s ability to bring suit or enforce this Agreement in any
other jurisdiction.

 

ARTICLE
X

ASSIGNEMNT;
TERMINATION

 

10.1       Assignment.
Neither this Agreement nor any rights of the parties hereto may be assigned or delegated to any other Person.

 

    	24

    	 

    

 

10.2       Termination.

 

(a)          This
Agreement and the obligations of Investor to make Advances hereunder shall terminate on the earlier to occur of: (i) twenty-four
(24) months after the Registration Statement is declared effective; or (ii) six (6) months after the “Late Effective Deadline”
(as such term is defined in the Registration Rights Agreement), if the Registration Statement has not been declared effective
by such date.

 

(a)          This
Agreement and the obligation of the Investor to make an Advance to the Company pursuant to this Agreement shall terminate permanently
(including with respect to an Advance Settlement Date that has not yet occurred) in the event that: (i) there shall occur any
stop order or suspension of the effectiveness of the Registration Statement for an aggregate of fifty (50) Trading Days, other
than due to the acts of the Investor, during the Commitment Period (provided, however, that this termination provision shall not
apply to any period commencing upon the filing of a post-effective amendment to such Registration Statement and ending upon the
date on which such post-effective amendment is declared effective by the SEC); or (ii) the Company shall at any time fail to comply
with any of the terms, covenants or provisions of this Agreement or the Registration Rights Agreement on the part of the Company
to comply with, and such failure is not cured within twenty (20) days after receipt of written notice from the Investor.

 

(b)          Nothing
in this Section 10.2 shall be deemed to release the Company from any liability for any breach under this Agreement, or to impair
the rights of the Investor to compel specific performance by the Company of its obligations under this Agreement or the Registration
Rights Agreement. The indemnification provisions contained in Article V shall survive termination hereunder.

 

ARTICLE
XI 

NOTICES

 

Any
notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement must
be in writing and in each case properly addressed to the party to receive the same in accordance with the information below, and
will be deemed to have been delivered: (i) if mailed by certified mail, return receipt requested, postage prepaid and properly
addressed to the address below, then three (3) business days after deposit of same in a regularly maintained U.S. Mail receptacle;
or (ii) if mailed by Federal Express, UPS or other nationally recognized overnight courier service, next business morning delivery,
then one (1) business day after deposit of same in a regularly maintained receptacle of such overnight courier; or (iii) if hand
delivered, then upon hand delivery thereof to the address indicated on or prior to 5:00 p.m., EST, on a Trading Day. Any notice
hand delivered after 5:00 p.m., EST, shall be deemed delivered on the following Trading Day. Notwithstanding the foregoing, notice,
consents, waivers or other communications referred to in this Agreement may be sent by facsimile, e-mail, or other method of delivery,
but shall be deemed to have been delivered only when the sending party has confirmed (by reply e-mail or some other form of written
confirmation from the receiving party) that the notice has been received by the other party. The addresses and facsimile numbers
for such communications, except for Advance Notices which shall be delivered in accordance with Section 2.1 hereof, shall be:

 

	If
to the Company, to:
	Millennium
    Healthcare, Inc.
	 	400 Garden city,
    NY 11530
	 	Suite 440
		Attention:  
    Dominick Sartorio, CEO
	 	Telephone:   516
    628-5500
	 	Facsimile:     516
    628-5400
	 	E-Mail: Dominick
    @ Millennium HCS.com

 

 

    	25

    	 

    

 

	With a copy
    to:	Lucosky Brookman
    LLP
	(which shall
    not constitute notice)	33
    Wood Avenue South, 6th  Floor
	 	Iselin,
    New Jersey  08830
	 	Attention:
     Seth Brookman,  Esq.
	 	Telephone:
    (732) 395-4400
	 	Facsimile:     (732)
395-4401
		E-Mail:  
            sbrookm an@lucbro.com
	 	 
	If to the Investor:	TCA Global Credit Master Fund, LP
	 	1404 Rodman
    Street
	 	Hollywood, Florida
    33020
	 	Attention:
     Robert Press,  Director
	 	Telephone:
    (786) 323-1650
		Facsimile:    (786)
    323-1651 
	 	E-Mail:    
         bpress@trafcap.com
	 	 
	With a copy
    to:	David Kahan,
    P.A.
	(which shall
    not constitute notice)	6420 Congress
    Ave., Suite  1800
	 	Boca Raton,
    Florida 33487 
	 	Telephone: (561)
    672-8330
	 	Facsimile:   (561)
    672-8301
	 	E-Mail: 
            david@dkpalaw.com

 

ARTICLE
XII 

MISCELLANEOUS

 

12.1        Execution;
Counterparts. This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and
considered one and the same Agreement, and same shall become effective when counterparts have been signed by each party and each
party has delivered its signed counterpart to the other party. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format file or other similar format file, such signature shall be deemed an original
for all purposes and shall create a valid and binding obligation of the party executing same with the same force and effect as
if such facsimile or “.pdf” signature page was an original thereof.

 

12.2        Entire
Agreement; Amendments. This Agreement, together with the Registration Rights Agreement, supersedes all other prior oral or
written agreements between the Investor, the Company, their affiliates and Persons acting on their behalf with respect to the
matters discussed herein, and this Agreement, and the instruments referenced herein, including the Registration Rights Agreement,
contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically
set forth herein or therein, the Investor makes no representation, warranty, covenant or undertaking with respect to such matters.
No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the party to be charged
with enforcement.

 

    	26

    	 

    

 

12.3      Reporting
Entity for the Common Stock. The reporting entity relied upon for the determination of the trading price or trading volume
of the Common Stock on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto.
The written mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

 

12.4      Fees.

 

(a)          Legal
and Administrative Fee. Each of the parties shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated hereby.

 

(b)          Advance
Fee. On each Advance Settlement Date, the Company shall pay to the Investor the Advance Fee with respect to each Advance made
hereunder, which Advance Fee shall be deducted by Investor out of the gross proceeds of each Advance.

 

12.5          Brokerage.
Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or broker
who will demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor, on the other
hand, agree to indemnify the other against and hold the other harmless from any and all liabilities to any person claiming brokerage commissions or finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party in
connection with this Agreement or the transactions contemplated hereby.

 

12.6          Confidentiality.
If for any reason the transactions contemplated by this Agreement are not consummated, each of the parties hereto shall keep
confidential any information obtained from any other party (except information publicly available or in such party’s domain prior
to the Effective Date, and except as required by court order) and shall promptly return to the other parties all schedules, documents,
instruments, work papers or other written information without retaining copies thereof, previously furnished by it as a result
of this Agreement or in connection herein.

 

[SIGNATURES
ON THE FOLLOWING PAGE]

 

    	27

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the Effective Date.

 

	 	COMPANY:
	 	 
	 	MILLENNIUM
        HEALTHCARE, INC.

	 	 
	 	By:	/s/
    Dominick Sartorio, CEO
	 	Name:	DOMINICK SARTORIO
	 	Title:	CEO

 

	 	INVESTOR:
	 	 
	 	TCA
    GLOBAL CREDIT MASTER FUND, LP
	 	 	 
	 	By:	TCA  Global
     Credit  Fund  GP,  Ltd.,  its  general partner
	 	 	 
	 	By:	 
	 	 	Robert Press,
    Director

 

    	28

    	 

    

 

EXHIBIT
“A”

 

FORM
OF ADVANCE NOTICE

 

[MILLENNIUM
HEALTHCARE, INC. LETTERHEAD]

 

The
undersigned,                             ,
hereby certifies, with respect to the sale of shares of Common Stock of Millennium Healthcare, Inc. (the “Company”)
issuable in connection with this Advance Notice, which Advance Notice is being delivered pursuant to the Committed Equity Facility
between the Company and TCA Global Credit Master Fund, LP dated as of August 31, 2012 (the “Agreement”),
as follows:

 

1.          The
undersigned is the duly elected                                              of
the Company.

 

2.          There
are no fundamental or material changes to the information set forth in the Registration Statement which would require the Company
to file a post-effective amendment to the Registration Statement.

 

3.          The
Company has performed all of the covenants and agreements to be performed by the Company under the Agreement, and the Company
has complied in all material respects with all obligations and conditions contained in the Agreement on or prior to the Advance
Notice Date, and the Company shall continue to perform and comply with all covenants and agreements to be performed by the Company
through the applicable Advance Settlement Date. All conditions under the Agreement to the delivery of this Advance Notice are
satisfied as of the date hereof. Since the date of the Company’s last financial statements, there has been no Material Adverse
Change.

 

4.          The
undersigned hereby represents, warrants and covenants that it has made all filings (“SEC Filings”) required
to be made by it pursuant to applicable securities laws (including, without limitation, all filings required under the Securities
Exchange Act of 1934). All SEC Filings and other public disclosures made by the Company, including, without limitation, all
press releases, analyst’s meetings, calls, etc. (collectively, the “Public Disclosures”), have been
reviewed and approved for release by the Company’s attorneys or general counsel and, if containing financial information, the
Company’s independent certified public accountants. None of the Company’s Public Disclosures contain any untrue statement of
a material fact, or omit to state a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.

 

5.          The
Advance requested by this Advance Notice is for the sale of                    Shares.

 

6.          4.99%
of the outstanding Common Stock of the Company as of the date hereof is                     .

 

7.          The
sale of the number of Shares requested by this Advance Notice does not exceed the Ownership Limitation, the Registration Limitation,
the Maximum Advance Amount or the Commitment Amount.

 

    	 

    	 

    

 

The
undersigned has executed this Advance Notice as of the _       _ day of                 20        .

 

MILLENNIUM HEALTHCARE, INC.

 

	By:	 	 
	Name: 	 	 
	Title:	 	 

 

Please deliver this Advance Notice by mail, e-mail or facsimile with a follow up phone call to:

 

	 	 
	 	 
	 	 
	 	 

 

    	 

    	 

    

 

EXHIBIT
“B”

 

FORM
OF SETTLEMENT DOCUMENT

 

Via
E-Mail and Facsimile

Millennium
Healthcare, Inc.

Attn:
CEO

Fax:                                

E-Mail:                            

 

Below
please find the settlement information with respect to the Advance Notice dated:                                    

 

	 	 	 
		(a)
    Amount of Advance Notice:	$
	1.	 	 
	 	(b)
        Amount of Advance Notice after adjusting for Ownership

        Limitation, Registration Limitation, Maximum Advance Amount and Committed Amount, if applicable :
	$
	 	 	 
	2.	Market
     Price: (VWAP of the Common  Stock during the relevant Pricing Period of                      to
                           ).	$
	 	 	 
	3.	Purchase
    Price (Market Price X 95%) per share:	$
	 	 	 
	4.	Number
    of Shares due to Investor computed by dividing 1(b) above by 3 above:	 

 

Please
issue the number of Shares due to the Investor to the account of the Investor as follows:

 

	 	 
	 	 
	 	 

 

	 	Sincerely,
	 	 
	 	TCA Global Credit
    Master Fund, LP

 

Approved
by:

 

MILLENNIUM
HEALTHCARE, INC.

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

    	 

    	 

    

 

EXHIBIT
“C”

 

REQUIRED
OPINIONS

 

1.          The
Company is a corporation validly existing and in good standing under the laws of Delaware, with corporate power and authority
to own, lease and operate its properties and to conduct its business as described in the Company’s latest Form 10-K or 10-Q (or
similar form for filing a quarterly or annual report) filed by the Company under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and the rules and regulations of the SEC thereunder (the “Public Filings”)
and to enter into and perform its obligations under the Committed Equity Facility Agreement (the “Agreement”).
The Company is also duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in
which the nature of the business conducted by it as described in the Public Filings makes such qualification necessary.

 

2.          The
Company has the requisite corporate power and authority to enter into and perform its obligations under the Agreement and to issue
the Shares in accordance with their terms. The execution and delivery of the Agreement by the Company and the consummation by
it of the transactions contemplated thereby have been duly authorized by all necessary corporate action, and no further consent
or authorization of the Company or its Board of Directors or stockholders is required. The Agreement, and each document executed
or delivered in connection therewith, has each been duly executed and delivered, and the Agreement, and each document executed
or delivered in connection therewith, each constitutes valid and binding obligations of the Company, enforceable against the
Company in accordance with their respective terms, except as my be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies.

 

3.          The
Shares are duly authorized and, upon issuance in accordance with the term of the Agreement, will be duly and validly issued,
fully paid and non-assessable, free of any liens, encumbrances and preemptive or similar rights contained, to our knowledge,
in any agreement filed by the Company as an exhibit to the Company’s Public Filings.

 

4.          The
execution, delivery and performance of the Agreement by the Company will not: (i) result in a violation of the Company’s Certificate
of Incorporation or By-Laws; (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement
or, indenture by which the Company or any of its assets or properties is bound, including, without limitation, and agreement or
document filed by the Company as an exhibit to the Company’s Public Filings; or (iii) to our knowledge, result in a violation
of any foreign, federal, state or local law, rule or regulation, order, judgment or decree applicable to the Company.

 

5.          To
our knowledge, and other then as set forth in the Public Filings, there are no legal or governmental proceedings pending to which
the Company is a party or of which any property or assets of the Company is subject which is required to be disclosed in any Public
Filings.REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION
RIGHTS AGREEMENT (the "Agreement") is dated as of the 31st day of August, 201 2, and made effective as of the
"Effective Date" (as defined in the CEF Agreement), by and between MILLENNIUM HEALTHCARE, INC., a Delaware corporation
(the "Company") and TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the "Investor").

 

WHEREAS, in
connection with the Committed Equity Facility Agreement by and between the Company and Investor of even date herewith (the "CEF
Agreement "), the Company has agreed, upon the terms and subject to the conditions of the CEF Agreement , to issue and
sell to the Investor that number of shares of the Company's common stock, $0.000 1 par value per share (the "Common Stock"),
which can be purchased pursuant to the terms of the CEF Agreement for an aggregate purchase price of up to Two Million Dollars
($2,000,000). Capitalized terms used in this Agreement and not otherwise defined herein shall have the meaning ascribed to such
terms in the CEF Agreement ; and

 

WHEREAS, in
order to induce the Investor to execute and deliver the CEF Agreement, the Company has agreed to provide certain registration
rights to the Investor under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the "Securities Act"), and applicable state securities laws;

 

NOW, THEREFORE
, in consideration of the promises and mutual covenants contained herein and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

I.    Definitions. As
used in this Agreement, the following terms shall have the following meanings (to the extent any of the following defined terms
are also defined in the CEF Agreement, the definition s below shall control for purposes of this Agreement):

 

(a)          "Person"
means a corporation , a limited liability company, an association, a partnership , an organization, a business, an individual
, a governmental or political subdivision thereof or a governmental agency.

 

(b)          "Register
," "Registered ," and "Registration, " whether capitalized herein or not , refer to a registration
effected by preparing and filing one or more "Registration Statements" (as defined below) in compliance with the Securities
Act and pursuant to Rule 415 under the Securities Act or any successor rule providing for offering securities on a continuous or
delayed basis ("Rule 415"), and the declaration or ordering of effectiveness of such Registration Statement(s)
by the SEC.

 

(c)          "Registrable
Securities" shall have the same meaning ascribed to such term in the CEF Agreement.

 

(d)          "Registration Statement"
means a registration statement under the Securities Act which covers the Registrable Securities.

 

    	 

    	 

    

 

2.          .              Registration.

 

(a)          Mandatory Registration.
The Company shall prepare and file with the SEC, no later than ninety (90) days from the Effective Date (as defined in the CEF
Agreement) (the "Scheduled Filing Deadline ") , a Registration Statement
on Form S-1 or on such other form as is available to the Company. The Company shall use its
commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC by a date that is no later
than one hundred fifty ( 150) days from the Effective Date (the "Scheduled Effective Deadline"),
and in any event, the Registration Statement shall be declared effective by the SEC prior to the first sale to the Investor
of the Company's Common Stock pursuant to the CEF Agreement. The Company shall cause the Registration Statement to remain effective
until the full completion of the Commitment Period.

 

(b)          Sufficient
Number of Shares Registered. The Registration Statement to be filed by the Company pursuant to Section 2(a) above shall register
for resale thereunder an amount of shares of the Company's Common Stock that is at least three (3) times the number of Registrable
Securities issuable to the Investor under the CEF Agreement (subject to limitations imposed by Rule 415). In the event the number
of shares available under a Registration Statement filed pursuant to Section 2(a) is insufficient to cover all of the Registrable
Securities pursuant to the CEF Agreement , the Company shall amend the Registration Statement , or file a new Registration Statement
(on the short form available therefor , if applicable), or both , so as to cover all of such Registrable Securities pursuant to
the CEF Agreement as soon as practicable, but in any event not later than fifteen ( 15) days after the necessity therefor arises.
The Company shall cause such amendment and/or new Registration Statement to become effective as soon as practicable following the
filing thereof. For purposes of the foregoing provision , the number of shares available under a Registration Statement shall be
deemed "insufficient to cover all of the Registrable Securities" if at any time the number of Registrable Securities
issuable on an Advance Notice Date is greater than the number of shares available for resale under such Registration Statement.

 

(c)          Failure to
Timely File Registration Statement. In the event the Registration Statement is not declared effective by the SEC by a date that
is no later than one hundred eighty ( 1 80) days from the earlier to occur of: (A) the date the Registration Statement is filed;
or (8) the Scheduled Filing Deadline (the "Late
Effective Deadline"), then in addition to any and all remedies Investor may have at law, in equity or under
the CEF Agreement or this Agreement , the Company shall be obligated to pay to Investor, in lawful money of the United States
of America by wire transfer to an account designated by Investor, within three (3) Trading Days from the Late Effective Deadline,
and monthly thereafter , as applicable, until the earlier to occur of: (i) the Registration Statement is declared effective by
the SEC; or (ii) until the "Maximum Cap" (as hereinafter defined) is reached , an amount equal to Two Thousand Five
Hundred and No/ 1 00 Dollars ($2,500.00) , up to a total maximum payment under this Section 2(c) that equals one-half percent
(0.5%) of the Commitment Amount (the "Maximum Cap").  The
Company acknowledges that this fee is to offset certain costs and damages incurred by Investor and attributable to the delay caused
by the Company's failure to have the Registration Statement declared effective by the SEC by the Late Effective Deadline, and
these sums shall not be deemed or construed as a penalty.

 

		3.	Related Obligations.

 

(a)          The Company
shall keep the Registration Statement effective pursuant to Rule 41 5 at all times until the completion of the Commitment Period
(the "Registration Period"), which Registration Statement (including
any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein , or necessary to make the statements therein , in light of
the circumstances in which they were made, not misleading.

 

    	2

    	 

    

 

(b)          The
Company shall prepare and file with the SEC such amendments (including post- effective amendments) and supplements to a
Registration Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be
filed pursuant to Rule 424 promulgated under the Securities Act , as may be necessary to keep such Registration Statement
effective at all times during the Registration Period, and , during such Registration Period , comply with the provisions of
the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by such Registration
Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended
methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. In the case of
amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including
pursuant to this Section 3(b)) by reason of the Company's filing a report on Form I 0-K, Form I 0-Q or Form 8-K or any
analogous report under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company
shall have incorporated such report by reference into the Registration Statement, if applicable, or shall file such
amendments or supplements with the SEC within three (3) business days following the day on which the Exchange Act report is
filed which created the requirement for the Company to amend or supplement the Registration Statement.

 

(c)          The Company
shall furnish to the Investor without charge: (i) at least one copy of the Registration Statement as declared effective by the
SEC and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference,
all exhibits and each preliminary prospectus; (ii) ten ( 10) copies of the final prospectus included in such Registration Statement
and all amendments and supplements thereto (or such other number of copies as the Investor may reasonably request); and (iii) such
other documents as the Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable
Securities owned by the Investor.

 

(d)          The Company
shall : (i) register and qualify the Registrable Securities covered by a Registration Statement under such other securities or
"blue sky" laws of such jurisdictions in the United States as the Investor reasonably requests; (ii) prepare and file
in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and qualifications
as may be necessary to maintain the effectiveness thereof during the Registration Period ;(iii) take such other actions as may
be reasonably necessary to maintain such registrations and qualifications in effect at all times during the Registration Period;
and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions;
provided , however , that the Company shall not be required in connection therewith or as a condition thereto to: (w) make any
change to its certificate of incorporation or by-laws; (x) qualify to do business in any jurisdiction where it would not otherwise
be required to qualify but for this Section 3(d); (y) subject itself to general taxation in any such jurisdiction; or (z) file
a general consent to service of process in any such jurisdiction . The Company shall promptly notify the Investor of the receipt
by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable
Securities for sale under the securities or "blue sky" laws of any jurisdiction in the United States or its receipt of
actual notice of the initiation or threat of any proceeding for such purpose.

 

    	3

    	 

    

 

(e)          As promptly
as practicable after becoming aware of such event or development, the Company shall notify the Investor in writing of the happening
of any event or development, the result of which would mean that the prospectus included in a Registration Statement, as then in
effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary
to make the statements therein , in light of the circumstances under which they were made, not misleading (provided that in no
event shall such notice contain any material, nonpublic information), and promptly prepare a supplement or amendment to such Registration
Statement to correct such untrue statement or omission, and deliver ten ( 1 0) copies of such supplement or amendment to the Investor,
and the Investor shall immediately cease any sales of securities until such amendment or supplement is filed. The Company shall
also promptly notify the Investor in writing: (i) when a prospectus or any prospectus supplement or post effective amendment has
been filed, and when a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness
shall be delivered to the Investor by facsimile or e-mail on the same day of, or the next business day following, such effectiveness);
(ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus or related information;
and (iii) of the Company's reasonable determination that a post-effective amendment to a Registration Statement would be appropriate.

 

(f)     The Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension
of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale
in any jurisdiction within the United States of America and , if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and to immediately notify the Investor of the issuance of such order
and the resolution thereof, or of the Company's receipt of actual notice of the initiation or threat of any proceeding for such
purpose.

 

(g)          Upon request
of the Investor, the Company shall furnish to the Investor, on the date of the effectiveness of the Registration Statement, and
thereafter from time to time on such dates as Investor may reasonably request: (i) a letter, dated such date, from the Company's
independent certified public accountants in form and substance as is customarily given by independent certified public accountants
to underwriters in an underwritten public offering; and (i i) an opinion, dated as of such date, from counsel representing the
Company for purposes of such Registration Statement, in form, scope and substance as is customarily given to an underwriter in
an underwritten public offering, addressed to the Investor.

 

(h)          The Company
shall make available for inspection by: (i) the Investor; and (ii) Investor's accountant s, attorneys, underwriters and other agents
retained by the Investor (collectively, the "Inspectors") all pertinent financial
information and other records, and pertinent corporate document s and properties of the Company (collectively, the "Records"),
as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the Company's
officers, directors and employees to supply all information which any Inspector may reasonably request in connection with the
Registration Statement. The Investor agrees that Records obtained by it as a result of such inspect ions which are conspicuously
marked by the Company as "Confidential"(subject to the Company's obligations with respect to material non-public information
set forth in Section 8. 1(a) of the CEF Agreement) shall be deemed confidential and held in strict confidence by the Investor,
unless: (x) the disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement
or is otherwise required under the Securities Act; (y) the release of such Records is ordered pursuant to a final, non appealable
subpoena or order from a court or government body of competent jurisdiction; or (z) the information in such Records has been made
generally available to the public other than by disclosure in violation of this or any other agreement of which the Inspector and
the Investor has knowledge. The Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by
a court or governmental body of competent jurisdiction or through other mean s, give prompt notice to the Company and allow the
Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, the Records
deemed confidential.

 

    	4

    	 

    

 

(i)           The Company
shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless: (i)
disclosure of such information is necessary to comply with federal or state securities laws; (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement; (iii) the release of such information
is ordered pursuant to a subpoena or other final , non-appealable order from a court or governmental body of competent jurisdiction;
or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement
or any other agreement. The Company agrees that it shall , upon learning that disclosure of such information concerning the Investor
is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to
the Investor and allow the Investor, at the Investor's expense, to undertake appropriate action to prevent disclosure of, or to
obtain a protective order for, such information.

 

(j)           The Company
shall use its commercially reasonable efforts either to cause all the Registrable Securities covered by a Registration Statement:
(i) to be listed on each securities exchange on which securities of the same class or series issued by the Company are then listed,
if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange; or (ii) to secure the
inclusion for quotation on the National Association of Securities Dealers, Inc. OTC Bulletin Board for such Registrable Securities.
The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(j).

 

(k)          The Company
shall cooperate with the Investor to the extent applicable, to facilitate the timely preparation and delivery of certificates (not
bearing any restrictive legend ) representing the Registrable Securities to be offered pursuant to a Registration Statement and
enable such certificates to be in such denominations or amounts, as the case may be, as the Investor may reasonably request and
registered in such names as the Investor may request.

 

(1)          The Company
shall use its commercially reasonable efforts to cause the Registrable Securities covered by the applicable Registration Statement
to be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition
of such Registrable Securities.

 

(m)         The Company
shall make generally available to its security holders as soon as practical , but not later than ninety (90) days after the close
of the period covered thereby, an earnings statement (in form complying with the provisions of Rule 158 under the Securities Act)
covering a twelve month period beginning not later than the first day of the Company's fiscal quarter next following the effective
date of the Registration Statement; provided , however, if the Company is a then "reporting company" with the SEC, then
so long as the Company is current in its filings with the SEC, the requirement to deliver the earnings statement required hereby
shall not be effective.

 

(n)          The Company
shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.

 

    	5

    	 

    

 

(o)          Within three
(3) business days after a Registration Statement which covers Registrable Securities is ordered effective by the SEC, the Company
shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form
attached hereto as Exhibit "A".

 

(p)          The Company
shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
pursuant to a Registration Statement.

 

4.          Obligations of the Investor. The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of
the kind described in Section 3(f) or the first sentence of 3(e), the Investor will immediately discontinue disposition of Registrable
Securities pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor's receipt of the
copies of the supplemented or amended prospectus contemplated by Section 3(e) or receipt of notice that no supplement or amendment
is required. Notwithstanding anything contained herein or in the CEF Agreement to the contrary, the Company shall cause its transfer
agent to deliver unlegended certificates for shares of Common Stock to a transferee of the Investor in accordance with the terms of the CEF Agreement in connection with any sale of Registrable Securities with respect to which the Investor has entered into
a contract for sale prior to the Investor's receipt of a notice from the Company of the happening of any event of the kind described
in Section 3(f) or the first sentence of 3(e) and for which the Investor has not yet settled.

 

5.          Expenses of
Registration . All expenses incurred in connection with registrations, filings or qualifications pursuant to this Agreement,
including, without limitation, all registration , listing and qualifications fees, printers' fees, and legal and accounting
fees shall be paid by the Company.

 

6.          Indemnification.
With respect to Registrable Securities which are included in a Registration Statement under this Agreement:

 

(a)          To the fullest
extent permitted by law, the Company will, and does hereby agree to indemnify, hold harmless and defend the Investor, the directors,
officers, partners , employees, agents, representatives of, and each Person , if any, who controls the Investor within the meaning
of the Securities Act or the Exchange Act (each, an "Indemnified Person"), against
any losses, claims, demands, threats, damages, liabilities, judgments, fines, penalties, charges, costs, reasonable attorneys'
and paralegals' fees, amounts paid in settlement or any other expenses of any nature whatsoever, joint or several (collectively,
the "Indemnified Damages ") incurred in investigating, preparing or
defending any action , claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court
or govern mental, administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an
Indemnified Person is or may be a party thereto (collectively, the "Claims"), to
which any Indemnified Person may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened,
in respect thereof) arise out of or are based upon : (i) any un true statement or alleged un true statement of a material fact
in a Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification
of the offering under the securities or other "blue sky" laws of any jurisdiction in which Registrable Securities are
offered ("Blue Sky
Filing"),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make
the statements therein not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any
final prospectus (as amended or supplemented , if the Company files any amendment thereof or supplement thereto with the SEC)
or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light
of the circumstances under which the statements therein were made, not misleading; or (iii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to a Registration Statement (the matters in the foregoing clauses (i
) through (iii) being , collectively, the "Violations"). The Company shall reimburse each Indemnified Person
promptly as such Indemnified Damages are incurred and are due and payable , in connection with investigating or defending any such
Claim . Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a):
(x) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon
and in conformity with information furnished in writing to the Company by such Indemnified Person expressly for use in connection
with the preparation of the Registration Statement or any such amendment thereof or supplement thereto; (y) shall not be available
to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the then-current prospect
us made available by the Company, if such prospectus was timely made available by the Company pursuant to Section 3(e); and (z)
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of
the Company, which consent shall not be unreasonably withheld, conditioned or delayed. Such indemnity shall remain in full force
and effect regardless of any investigation made by or on behalf of the Indemnified Person.

 

    	6

    	 

    

 

(b)          In
connection with a Registration Statement , the Investor agrees to indemnify, hold harmless and defend , to the same extent and
in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers, employees, representatives
or agents and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (each
an "Indemnified Party"),
against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act , the Exchange
Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the
extent , and only to the extent , that such Violation occurs directly as a result of the Company's reliance upon written information
furnished to the Company by the Investor expressly for use in connection with such Registration Statement; and, subject to Section
6(d), the Investor will reimburse any legal or other expenses reasonably incurred by them in connection with investigating or defending
any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect to
contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Investor, which consent shall not be unreasonably withheld; provided, further, however,
that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed
the net proceeds to the Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party.  Notwithstanding
anything to the contrary contained herein , the indemnification agreement contained in this Section 6(b) with respect to any prospect
us shall not inure to the benefit of any Indemnified Party if the untrue statement or omission of material fact contained in the
prospectus was corrected and such new prospectus was delivered to the Investor prior to the Investor's use of the prospectus to
which the Claim relates.

 

    	7

    	 

    

 

(c)          Promptly after
receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of a n y Claim (including
any governmental action or proceeding), such Indemnified Person or Indemnified Party shall, if a Claim in respect thereof is to
be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice of the commencement
of the Claim and all other information in the possession of the Indemnified Person or Indemnified Party , and the indemnifying
party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying
party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party
and the Indemnified Person or the Indemnified Party , as the case may be; provided, however, that an Indemnified Person or Indemnified
Party shall have the right to retain its own counsel with the fees and expenses of not more than one counsel for such Indemnified
Person or Indemnified Party to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying
party, the representation by such counsel of the Indemnified Person or Indemnified Part y and the indemnifying party would be inappropriate
due to actual or potential conflicts of interest between such Indemnified Person or Indemnified Party and any other party represented
by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party
in connection with any negotiation or defense of any such Claim and shall furnish to the indemnifying party all information reasonably
available to the Indemnified Party or Indemnified Person which relates to such Claim. The indemnifying party shall keep the Indemnified
Party or Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect
thereto. No indemnifying party shall be liable for any settlement of any Claim effected without its prior written consent, provided,
however, that the indemnifying party shall not unreasonably withhold , delay or condition its consent. No indemnifying party shall
, without the prior written consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into
any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff
to such Indemnified Party or Indemnified Person of a full and unconditional release from all liability in respect to such Claim.
Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified
Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification
has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of
any such Claim shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under
this Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend such Claim .

 

(d)          The indemnification
required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation or
defense, as and when bills are received or Indemnified Damages are incurred.

 

(e)          The indemnity
agreements contained herein shall be in addition to: (i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to
the law.

 

7.          Contribution.
To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make
the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent
permitted by law; provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within
the meaning of Section 1 1(f) of the Securities Act) shall be entitled to contribution from
any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of
Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller from the sale of such Registrable
Securities.

 

    	8

    	 

    

 

8.          Reports Under
the Exchange Act. With a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act
or any similar rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the
public without registration ("Rule 144"), from and after the "Reporting
Date"(as defined in the CEF Agreement), so long as the Investor owns any Registrable Securities, the Company agrees to:

 

(a)          defined make and keep public information
available, as those terms are understood and in Rule 144;

 

(b)          file with the
SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so
long as the Company remains subject to such requirements (it being understood that nothing herein shall limit the Company's obligations
under the CEF Agreement) and the filing of such reports and other documents is required for the applicable provisions of Rule 144;
and

 

(c)          furnish to
the Investor so long as the Investor owns Registrable Securities, promptly upon request: (i) a written statement by the Company
that it has complied with the reporting requirements of Rule 1 44, the Securities Act and the Exchange Act; (ii) a copy of the
most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii)
such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without
registration and without any limitations or restrictions .

 

9.          Amendment
of Registration Right s. Provisions of this Agreement may be amended and the observance thereof may be waived (either generally
or in a particular instance and either retroactively or prospectively), only by a written agreement between the Company and the
Investor. Any amendment or waiver effected in accordance with this Section 9 shall be binding upon the Investor and the Company.

 

10.        Miscellaneous.

 

(a)          Record Owner.
A Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable
Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the
same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from the registered
owner of such Registrable Securities.

 

(b)          Further Assurances.
The Company hereby covenants and agrees to execute and deliver any additional documents necessary or desirable, in the reasonable
opinion of Investor, or their respective legal counsel, to carry out the intent of this Agreement or enforce its terms, and to
otherwise allow Investor to dispose of or re-sell all Registrable Securities, and any other shares of the Company's Common Stock
that may be owned by the Investor, whether or not same are Registrable Securities, including, without limitation, delivering, or
causing the Company's counsel to deliver, any opinions required to remove restrictive legends or to sell any such Registrable Securities
or other shares, either pursuant to an effective Registration Statement hereunder, or pursuant to Rule 144, or otherwise.

 

(c)          Notices. All
notices of request, demand and other communications hereunder shall be addressed to the parties as follows:

 

    	9

    	 

    

 

	If to the Company:	Millennium Healthcare, Inc.
	 	400 Garden City Plaza, Suite 440
	 	Garden City, NY 11530
	 	Attn: Mr. Dominick Sartorio, CEO 
	 	Telephone: 516-628-5500
	 	Facsimile: 516-628-5400
	 	E-Mail: Dominick@millenniumhcs.com
	 	 
	With a copy to:	Seth Brookman, Esq.
	(which shall not constitute notice )	Lucosky Brookman, LLP
	 	33 Wood Avenue South, 6th Floor 
	 	lselin, New Jersey 08830
	 	Phone: (732) 395-4400
	 	Fax : (732) 395-4401
	 	Ema il: sbrookman@lucbro.com
	 	 
	If to the In vestor:	TCA Global Credit Master Fund, LP 
	 	1404 Rodman Street
	 	Hollywood , FL 33020 
	 	Attn : Mr. Robert Press
	 	Telephone: (786) 323-1 650
	 	Facsimile: (786) 323- 1 65 1
	 	E-Mail : bpress@trafcap.com
	 	 
	With a copy to:	David Kahan , P.A.
	 	6420 Congress Ave., Suite 1800 
	 	Boca Raton , FL 33487
	 	Attn: David Kahan , Esq. Telephone: (56 1) 672-8330
	 	Facsimile: (561) 672-8301
	 	E-Mail: david@dkpalaw.com

 

unless the address
is changed by the party by like notice given to the other parties. Notice shall be in writing and shall be deemed received: (i)
if mailed by certified mail , return receipt requested , postage prepaid and properly addressed to the address above, then three
(3) business days after deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if mailed by Federal Express, UPS or other nationally recognized overnight courier service, next business morning delivery, then one (1) business day after deposit
of same in a regularly maintained receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof
to the address indicated on or prior to 5:00 p.m., EST, on a business day. Any notice hand delivered after 5:00 p.m ., EST, shall
be deemed delivered on the following business day. Notwithstanding the foregoing, notice, requests or demands or other communications
referred to in this Agreement may be sent by facsimile, e-mail , or other method of delivery, but shall be deemed to have been
delivered only when the sending party has con finned (by reply e-mail or some other form of written confirmation from the receiving
party) that the notice has been received by the other party.

 

    	10

    	 

    

 

(d)          Entire Agreement.
This Agreement, together with the CEF Agreement, contains the entire understanding and agreement of the parties relating to the
subject matter hereof and supersedes all prior and/or contemporaneous understandings and agreements of any kind and nature (whether
written or oral) among the parties with respect to such subject matter.

 

(e)          Governing
Law. The corporate laws of the State of Neva da shall govern all issues concerning the relative rights of the Company and the Investor
under this Agreement. All other questions concerning the construction , validity, enforcement and interpretation of this Agreement
shall be governed by the internal laws of the State of Nevada, without giving effect to any choice of law or conflict of law provision
or rule (whether of the State of Nevada or any other jurisdiction) that would cause the application of the laws of any jurisdiction
other than the Stat e of Nevada. Each party hereby irrevocably submits to the non exclusive jurisdiction of the State Courts of
the State of Nevada, sitting in Clark County , Nevada and the Federal District Court for the Di strict of Nevada , for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, provided, however,
that nothing herein shall prevent the Investor from bringing suit or taking legal action in any other jurisdiction , and the Company
hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit , action or proceeding by mailing a copy thereof to such party at the address for such notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRI AL FOR THE ADJUDICAT ION OF ANY
DISPUTE HEREUNDER OR IN CONNECT ION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY .

 

(f)           Severability. The parties agree that if any provision of this Agreement be held to be invalid, illegal or unenforceable
in any jurisdiction , that holding shall be effective only to the extent of such invalidity, illegally or unenforceability without
invalidating or rendering illegal or unenforceable the remaining provisions hereof, and any such in validity, illegally or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. It is the intent of
the parties that this Agreement be fully en forced to the fullest extent permitted by applicable law.

 

(g)          Binding Effect;
Assignment. This Agreement and the rights and obligations hereunder may not be assigned or delegated by either party, without
the prior written consent of the other party. This Agreement shall be binding upon and shall inure to the benefit of the parties
hereto and their respective successors and permitted assigns. This Agreement is intended for the benefit of the parties hereto
and their respective permitted successors and assign s, and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person .

 

(h)          Headings.
The section headings contained in this Agreement are inserted for reference purposes only and shall not affect in any way the meaning,
construction or interpretation of this Agreement. Any reference to the masculine, feminine, or neuter gender shall be a reference
to such other gender as is appropriate. References to the singular shall include the plural and vice versa.

 

    	11

    	 

    

 

(i)           Waiver.
A waiver of any breach or violation of any term, provision or covenant contained herein shall not be deemed a continuing waiver,
or a waiver of any future or past breach or violation, or a waiver of any other term , provision or covenant of this Agreement.
Any such waiver shall only be valid if it is writing and signed by the party granting such waiver.

 

(j)           Joint Preparation.
The preparation of this Agreement has been a joint effort of the parties and the resulting documents shall not, solely as a matter
of judicial construction, be construed more severely against one of the parties than the other.

 

(k)          Counterparts
and Execution. This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and considered
one and the same Agreement , and same shall become effective when counterparts have been signed by each party and each party has
delivered its signed counterpart to the other party.  In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a ".pdf ' format file or other similar format file, such signature shall be deemed an original for
all purposes and shall create a valid and binding obligation of the party executing same with the same force and effect as if such
facsimile or ".pdf ' signature page was an original thereof.

 

[Signatures on the following page]

 

    	12

    	 

    

 

IN WITNESS WHEREOF , the parties hereto
have executed this Agreement effective the day and year first above written.

 

	 	COMPANY:
	 	 
	 	MILLENNIUM HEALTHCARE, INC., a Delaware corporation
	 	 
	 	By:	Dominick Sartorio
	 	 	 
	 	Ti1tle:  	CEO
	 	 
	 	INVESTOR:
	 	 
	 	TCA GLOBAL CREDIT MASTER FUND, LP
	 	 
	 	By:	TCA Global Credit Fund GP, Ltd., its general partner
	 	 	 
	 	By:	 
	 	Name:	Robert Press
	 	Title:	Director

 

    	13

    	 

    

 

EXHIBIT "A"

 

FORM OF NOTICE OF EFFECTIVENESS 

 

OF REGISTRATION STATEMENT

 

	Attention:	TCA Global Credit Master Fund, LP
	 	 
	 	Re: Millennium Healthcare, Inc.

 

  Ladies and Gentlemen:

 

We are counsel to
Millennium Healthcare, Inc. (the "Company"), and have represented the Company in connection with that certain
Committed Equity Facility Agreement (the "CEF Agreement ") entered into by and between the Company and TCA Global
Credit Master Fund, LP (the "Investor") pursuant to which the Company issued, or proposes to issue, to the Investor
shares of its Common Stock, $0.000 I par value per share (the "Common Stock"). Pursuant to the CEF Agreement,
the Company also has entered into a Registration Rights Agreement with the Investor (the "Registration Rights Agreement")
pursuant to which the Company agreed, among other things, to register the Registrable Securities (as defined in the Registration
Rights Agreement) under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the
Company's obligations under the Registration Rights Agreement ,on                              , the Company filed a Registration Statement on Form        
(File No. 333-               (the "Registration
Statement") with the Securities and Exchange Commission (the "SEC") relating to the Registrable
Securities which names the Investor as a selling stockholder thereunder.

 

In connection with
the foregoing, we advise you that a member of the SEC's staff has advised us by telephone that the SEC has entered an order declaring
the Registration Statement effective under the Securities Act at (ENTER TIME OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS]
and we have no knowledge, after telephonic inquiry of a member of the SEC's staff, that any stop order suspending its effectiveness
has been issued or that any proceedings for that purpose are pending before , or threatened by, the SEC and the Registrable Securities
are available for resale under the Securities Act pursuant to the Registration Statement.

 

	 	Very truly yours, 	 
	 	 	 
	 	By:	 

 

    	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]